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Manuscript Preparation
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legends, etc. Liberal margins should be left at the top and bottom,
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(SI units).
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and figures.

References
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Be sure that legends and figures correspond.
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of the photo-graph. All restrictions must be strictly observed.
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European National Society Cardiovascular Journals:
Background, Rationale and Mission Statement of the "Editors' Club"
(Task Force of the European Society of Cardiology)
FERNANDO ALFONSO,1 GIUSEPPE AMBROSIO,2 FAUSTO J. PINTO,3 ERNST E. VAN DER WALL4
From Editors-in-Chief of 1Revista Española de Cardiología, published by the Spanish Society of Cardiology, 2(Former
Editor) Giornale Italiano di Cardiologia, published by the Italian Federation of Cardiology, 3Revista Portuguesa de
Cardiologia, published by the Portuguese Society of Cardiology, 4Netherlands Heart Journal, published by the
Netherlands Society of Cardiology and Chairman of the Task Force.
Anesti Kondili MD, Djamaleddine Nibouche MD, Karlen Adamyan MD, Kurt Huber MD, Hugo Ector MD, Izet
Masic MD, Rumiana Tarnovska MD, Mario Ivanusa MD, Vladimír Stan k MD, Jørgen Videbæk MD, Mohamed
Hamed MD, Alexandras Laucevicius MD, Pirjo Mustonen MD, Jean-Yves Artigou MD, Ariel Cohen MD, Mamanti
Rogava MD, Michael Böhm MD, Eckart Fleck MD, Gerd Heusch MD, Rainer Klawki MD, Panos Vardas MD,
Christodoulos Stefanadis MD, József Tenczer MD, Massimo Chiariello MD, Joseph Elias MD, Halima Benjelloun
MD, Olaf Rødevand MD, Piotr Ku akowski MD, Edvard Apetrei MD, Victor A. Lusov MD, Rafael G. Oganov MD,
Velibor Obradovic MD, Gabriel Kamensky MD, Miran F. Kenda MD, Christer Höglund MD, Thomas F. Lüscher
MD, René Lerch MD, Moufid Jokhadar MD, Habib Haouala MD, Vedat Sansoy MD, Valentin Shumakov MD, Adam
Timmis MD
(European National Society Cardiovascular Journals Editors, see Appendix for complete affiliations)
Carlos Daniel Tajer MD, Kathleen Coard MD, Rachel Hajar MD, Chu-Pak Lau MD, H K Chopra MD, Seyed
Abdolhossein Tabatabaei MD, Manlio Márquez MD, Abdus Samad MD, Javier Galeano MD, Anton Doubell MD,
Chi-Tai Kuo MD, Rungroj Krittayaphong MD, Kaduo Arai MD
(ESC Affiliated National Society Cardiovascular Journals Editors, see Appendix for complete affiliations)
Fernando Bacal MD, Luis Guzmán MD, PhD
(Other cardiac societies with official journal endorsing this document)

Cardiovascular scientific production in Europe
is growing both in quantity and in quality. Promoting
high-quality research is a major goal of the European
Society of Cardiology (ESC). 1-3 The ESC has two

Address for reprints: Dr. Fernando Alfonso
Revista Española de Cardiología, Sociedad Española de
Cardiología, Nuestra Señora de Guadalupe, 5-7, 28028 Madrid,
Spain
Email: rec@revespcardiol.org
Received June 16, 2009; accepted July 20, 2009.
* This manuscript will be simultaneously published in all Affiliated
National Societies Journals that consented to publication.
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highly respected official general journals, namely
the European Heart Journal and Cardiovascular
Research, devoted to clinical and basic research
respectively.1-3 The ESC also publishes several subspeciality official journals covering the full spectrum
of cardiovascular diseases and related techniques.
Most European countries, however, also have their
own cardiovascular journals. National Society
Cardiovascular Journals (NSCJ) are time-honoured
and classically disseminate high-quality scientific
research mainly originating from each particular
European country. They also play a major role in
education and harmonisation of clinical practice.
Most NSCJ are published in local languages but many
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of them also incorporate English editions. Altogether,
NSCJ provide a highly effective means to disseminate
cardiovascular research produced in Europe.
Scientific knowledge, however, has no barriers and
many of these journals have gained an undisputed
international profile. Some NSCJ, however, are just
emerging and would benefit from networking support.
It became clear that enhancing collaboration among
NSCJ Editors would facilitate advancement in
knowledge and further diffusion of scientific and
educative contents.
Developing a "Constitution Document" and
"Mission Statement" was considered desirable to set
the basis of future collaboration among NSCJ Editors.
We assumed this responsibility in recognising the
crucial role of NSCJ in Europe. Our target was to
produce and issue a core document with fundamental
principles upon which all NSCJ Editors would agree.
Common goals will be identified and agreed-on
measures will be pursued. The constitution document
presented herein was therefore developed to formalise
the NSCJ Editors' Club Task Force.

National Society Cardiovascular
Journals: Background and Basic Data
All Editors-in-Chief of the official
cardiovascular journals of the ESC National Societies
are de facto members of the Editors' Club. On April
2007, during the "spring days" at the Heart House in
Nice, the ESC Board formally approved the initiative
and the Editors' Club Task Force was officially
launched. The organisation of the Task Force consists
of a Nucleus of NSCJ Editors and remains within the
membership division of the ESC, coordinated by the
ESC vice-president. Further involvement of the ESC
publishing department will be also considered as
required.
The initial steps of the Editors' Club Task Force
moved in the direction to gain further insights on who
we are and where we are now. Accordingly, several
proactive measures were taken:
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1. Upon request of this Task Force, the portal on the
ESC web page for the NSCJ was modified to
increase its visibility. Currently, this site may be
reached, not only from the area corresponding to
members and National Societies, but also directly
from the scientific area of the ESC.4 It is clear that
NSCJ significantly contribute to the enormous
scientific input provided by the ESC as a whole
and appropriate recognition to this fact should be
granted.
2. Electronic communication brings the scientific
community closer together. Therefore, direct links
to NSCJ have been updated and implemented.4 This
would further stimulate exchange of scientific
research amongst European authors, researchers
and readers. Submission of high quality original
research articles should be encouraged by NSCJ
Editors, establishing efficient networking tools
connecting all European journals.
3. As a final preliminary step, the Task Force strived
to obtain detailed editorial and organisational data
from all corresponding journals. Accordingly,
feedback was directly requested from the NSCJ
Editors and Presidents of the National Societies.
A comprehensive structured questionnaire (23
items), was devised. Corporate mailing and
subsequent collection of all editorial data were
guaranteed with the help of the ESC membership
department. Consistency checks were performed
and, when required, data confirmation was directly
obtained from the corresponding national Editor.
Fully detailed results of this survey are currently
freely available from the ESC web page (metafile
of national journals).4 This posted material will be
updated annually.
Main results of the survey are as follows. A
total of 40 National Societies responded to the
structured questionnaire including a total of 34
journals. Eight National Societies have no official
journal, the 3 Baltic countries share the same Journal
and 3 National Societies have more than 1 journal.
The oldest cardiovascular journal in Europe is
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Archives des Maladies du Coeur et des Vaisseaux
founded in 1908. Overall, 11 journals have more than
30 years of existence, 2 are older than 20 years and
12 have been published for more than a decade. In
addition to NSCJ in local languages, 12 journals are
also available in English (full text) and 27 journals
systematically include English abstracts. Thirty-three
journals include original papers whereas 1 exclusively
consists of review papers or state of the art articles.
Thirteen journals are published monthly. The journals
print run varies from 1000 to 9000 copies (mean 3135
copies). A system of "peer review" is selected to
evaluate manuscripts by 31 journals and 23 journals
adhere to the requirements of the International
Committee of Medical Journals Editors. Twenty nine
journals are indexed (Index Medicus), 18 appear in
PubMed (MEDLINE) and 5 have obtained an impact
factor in 2006. In addition to the print edition, 26
journals have an electronic edition, and 13 have also
implemented an electronic system for manuscript
submission. A dedicated web page is offered by 25
journals whereas 26 publications are directly
accessible via the web page of the corresponding
national society.4

General Editorial Considerations
Both, technical and ethical considerations should
be addressed.5-8 Promoting editorial quality standards
is of paramount importance to increase the attractiveness
of our publications in the globalised and highly
competing field of academic cardiovascular medicine.
In this regard the Task Force believes that every effort
should be made to follow the uniform recommendations
initially issued by the International Committee of
Medical Journal Editors (ICMJE) nearly 30 years ago.
These recommendations have been recently updated
(6th edition) and the emphasis has shifted from the
original technical requirements (focused on unifying
technical and formal aspects of manuscript preparation),
to general principles of editorial ethics and global
policies that should govern biomedical publishing.5,8

J HK Coll Cardiol, Vol 17

Technical requirements are indeed important to
guarantee clarity, precision and to facilitate
dissemination of medical studies. In turn,
implementation and strict compliance with these
requirements eventually raises the overall quality of
research. In this regard, the suggestions provided
by the CONSORT (CONsolidated Standards Of
Reporting Randomised Trials) group should be
followed to improve presentation of randomised
clinical trials. 9 These studies should comply with
special requirements, including a check list and flow
diagram. We should keep in mind that cardiology is
one of the medical disciplines where performance of
randomised trials has more clearly fructified and the
concept of evidence-based medicine is widely
embraced.
Currently, online editions represent the most
efficient means for disseminating the information that
journals publish. Visits to electronic editions are
ever-increasing and full article downloads grow
exponentially.3,10 Therefore, electronic connectivity
should be facilitated so that online journal editions
are made more visible to readers and, if possible,
freely available. In this regard, a provocative novel
index, known as the "web impact factor", has been
proposed and the field of webometrics is just
emerging.
On the other hand, ethical considerations
directly affect the credibility of the scientific content.
Therefore, they should ensure transparency, trust
and honesty in the scientific process involved in
performance and publication of research.5-8 The final
purpose is to protect the process of scientific
exchange. It should be acknowledged that a sizable
bulk of corporative research has recently moved from
academic and university centres to close agreements
between sponsors and private contract research
organisations. Accordingly, explicitly disclosing the
role of the sponsor in designing, conducting,
analysing, interpreting and writing the trial is
becoming increasingly relevant. Other concepts such
as Editorial Freedom and Editorial Independence
have been recently emphasised by the ICMJE, WAME
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(Word Association of Medical Editors) and CSE
(Council of Science Editors). 5-8 Authority and
autonomy are critical to ensure appropriate editorial
decisions. In this regard, NSCJ Editors should
jealously safeguard the editorial independence of
their respective national journals.
T h e p e e r r ev i ew p r o c e s s − d e s p i t e i t s
limitations − has been enthroned at the highest level
and it is now currently identified as an essential part
of the editorial scientific process. Therefore,
standards for peer review excellence should be
developed. This requires both fairness in judgement
and expertise in the field. Editors are responsible for
monitoring and ensuring fairness, timeliness, and
thoroughness in this process.5-8
Other issues such as conflicts of interest (for
authors, reviewers and editors) and requirements for
authorship are also intended to protect the credibility
of the scientific information. Disclosure of potential
conflicts of interest should be enforced. Disclosure
on data accessibility and accepting a full
responsibility for accurate data presentation and
interpretation are key considerations. Confidentiality
and agreed-on embargos should be maintained.
Publication bias (selective reporting of positive
findings and lack of publication of studies with
negative results) should be prevented by NSCJ
Editors. The whole publication process is based on
the credibility, trust, authenticity and scientific
honesty.5-8 To further preserve scientific credibility,
NSCJ Editors should harmonise their policies regarding
scientific misconduct and scientific fraud. 11-16
The HEART Group (Heart Editors Action Round
Table) of cardiovascular editors issued a consensus
document focused on redundant publication. 12
Eventually, publishing "expression of concern" notes
or even retraction of published material should be
considered. Salami slicing and shotgunning
publication strategies should be discouraged and, at
least, disclosed.11-16 Secondary publications, even in
different languages, should follow the ICMJE
requirements.5
Finally, stimulating bibliometric indexes is of
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clear interest to gain international recognition. The
impact factor (Journal Citation Reports) represents
a widely accepted means to evaluate the scientific
prestige of journals. However, flaws in the impact
factor calculation should be acknowledged and
research or scholarly merits should not be rewarded
based on the impact factor of the journal in which
articles are eventually published. 2,17-19 Padding the
impact factor should be discouraged. However, NSCJ
Editors should develop common policies to stimulate
diffusion of European studies exclusively based on
scientific quality and clinical relevance criteria. This
would overcome current citation biases, particularly
against non-English biomedical journals. 17 Joint
support of European research by increasing
recognition of European scientific and editorial
quality is considered, therefore, highly advisable.

Rationale for the Editors' Club
European NSCJ are heterogeneous and, above
all, are published in different languages. This
highlights that cooperation among NSCJ Editors is
crucial to avoid "Tower of Babel" phenomena
precluding efficient dissemination of scientific
information across Europe. Even relatively humble
journals should not be condemned to ostracism but
rather considered highly successful providing they
h ave a b r o a d d i s s e m i n a t i o n a n d a re d e e p l y
appreciated by their readers. We should break
boundaries and set free scientific knowledge from any
constrictions generated by language, logistic,
bureaucratic or economic barriers. Cross-links
between European Journals are highly advisable.
Cross-references should be stimulated but only when
based on strict criteria of scientific quality. A minimal
list of important issues should be developed with
principles that all NSCJ Editors could agree upon.
Common goals, priorities and challenges should be
readily identifiable. Finally, proactive global
decisions should be made in order to capture a wider
audience.
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All the above described editorial
recommendations, however, leave enough room for
specific editorial policies that shape the particular
interest of every specific journal. Room for diversity
should be jealously maintained as the focus and scope
of different national journals actually differ.
Nevertheless, advancement in knowledge is founded
in the exchange of novel information by investigators,
and NSCJ Editors have full responsibility for
stimulating cooperation among European researches.
Here, we would like to present three typical
examples where these collaborative efforts could be
applicable:
1. Novel recommendations suggesting to register all
clinical trials prior to definitive publication should
be discussed on the light of currently available
administrative national laws and recent European
directives (EudraCT). Proposals for a uniform
European "Repository" of clinical trials fulfilling
not only administrative and regulatory issues but
also editorial requirements (including free public
access) should be considered.20,21 This will allow
early recognition of undue trial design changes or
methodological flaws. Eventually, most NSCJ
Editors could joint uniform recommendations and
common editorial policies and platforms might be
devised at a European level.
2. Collaboration among NSCJ Editors is essential to
further disseminate and promote clinical
application of ESC clinical practice guidelines.
After endorsement by National Societies,
translation of these guidelines into national local
languages should facilitate their implementation
into clinical practice.22-27 Foot notes, incorporating
comments of local experts, are pivotal in this
regard. Publication of these guidelines in NSCJ
should follow the general rules for "secondary
publication", after primary publication in the
European Heart Journal has been granted.
Nevertheless, time matters, and this detailed and
rigorous editorial process (typically affecting
uniquely long documents) should be expedited to
streamline the translation process and to monitor
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its accuracy. Implementation of an "early translation
process" would be desirable. A full collaboration
between NSCJ Editors and the ESC committee of
practice guidelines is, therefore, of paramount
importance. The circle of knowledge will be closed
when the corresponding feedback is ensured by
dissemination of selected national activity registries
unraveling local practices in patient care.28,29 This
will help to elucidate success, viability and
implementation of different ESC initiatives at the
national level. Hopefully, this bidirectional
exchange in knowledge will promote widespread
implementation of these recommendations and
harmonisation of cardiovascular practices across
Europe. Eventually, uniform and consistent clinical
practices should translate into improvements in
patient care.
3. Boosting dissemination of official ESC late
breaking clinical trials, by readily translating their
abstracts into local languages and publishing the
main results of these important studies, while
paying maximal attention to preserve accuracy and
scientific integrity, remains a challenge. 30,31 This
final proposal will require, once more, a close
coordination between ESC scientific bodies, ESC
publishing department and NSCJ Editors

Mission Statement
1. To increase collaboration among NSCJ Editors.
The main purpose of this Task Force is to foster
interaction among NSCJ Editors. Selected editorial
topics will be discussed and addressed using a
systematic and comprehensive approach. Standing
and "ad hoc" committees will be created. Common
editorial policies should be developed. As needed,
editorials, uniform requirements, and consensus
documents will be issued. Regular meetings
(annual ESC Congress and others) will be
scheduled and a formal agenda will be proposed.
2. To promote editorial excellence. A major objective
of the Task Force is to devise means to improve
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the scientific standards of NSCJ. Scientific content,
quality requirements, credibility, and editorial and
research ethics will be promoted.5-8
3. To improve diffusion of scientific knowledge.
Coordination of editorial initiatives among NSCJ
and also official ESC journals will further facilitate
diffusion of editorial and scientific content. To
develop common strategies to increase awareness
of the high quality scientific research generated in
Europe which, in turn, would positively affect
bibliometric indicators. Recognition and diffusion
of European cardiovascular research, ESC clinical
practice guidelines and other scientific or
education initiatives should be promoted.
Distribution of common academic material, core
curriculum, and additional teaching tools should
be also facilitated. Fostering of electronic editions
should be encouraged to increase diffusion and
NSCJ visibility.
4. To s h a re t e ch n i c a l e d i t o r i a l i n f o r m a t i o n,
experiences, initiatives, publishing resources and
technical tools among NSCJ Editors. To address
common issues regarding free access to scientific
content. To foresee common strategies to advance
into the dynamic field of standardised platforms
for manuscript submission. To adopt common
policies aimed to increase efficiency in the
publication process. To promote parallel electronic
and English-editions in an increasing number of
NSCJ and, eventually, sharing copy-editing
resources. To develop joint efforts to more
efficiently tackle the problem of finite editorial
resources, and finally, to ensure economic viability
of NSCJ.
5. To provide an operative framework and dataset
that will enable future joint ventures and
comprehensive European publishing initiatives. To
further stimulate collaboration between NSCJ
Editors and the ESC scientific bodies and
publishing department. In this way, promotion of
spotlight, theme or monographic issues, covering
burning cardiovascular topics, might be nicely
coordinated.
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6. Public relations. To provide a common voice when
issues concerning NSCJ arise. To serve as a liaison
in the relations with governmental bodies,
professional or scientific organisations, industry,
the media and the public.
7. To foster collaboration between National Societies
and the ESC. To close the gap between ESC official
journals and NSCJ. To promote European
incentives to stimulate publication of quality
research.

Final Remarks
All the information presented in the present
document set the basis to support this exciting
editorial initiative. NSCJ Editors should be
committed to progressively adapt their local policies,
including instructions to authors, to follow general
editorial recommendations.5-8,32,33 The main challenge
of the Editors Club will be to foster consensus and
agreements upon strategic priorities among NSCJ.
The breadth and quality of articles should be
improved and strategic actions should be aimed to
foster inclusion of most NSCJ in well respected
international bibliographic databases and electronic
search systems. Joint efforts should aim to broaden
distribution and dissemination of these journals and
to consolidate their prestige and recognition by the
international scientific community. The main goals
of this pioneering effort are, therefore, already quite
clear: to increase collaboration among NSCJ Editors,
enhance editorial standards, improve quality
requirements, preserve publication ethics, guarantee
scientific credibility and expand dissemination of
scientific knowledge.
Commitment of NSCJ Editors to achieve
these objectives is crucial and this Editors' Club
emerging forum should provide a unique
opportunity to foster global editorial policies.
Overtime, the results and implications of these
ambitious editorial initiatives should be critically
evaluated.
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Heart Rate Variability in Children with Congenital Heart Disease
Before and After Open Heart Surgery
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From 1Department of Cardiovascular Surgery; 2Department of Pediatric Cardiology, Mersin University Medical
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ÖZEREN ET AL.: Heart Rate Variability in Children with Congenital Heart Disease Before and After Open Heart
Surgery. Background: Spectrum analysis of heart rate variability (HRV) is a noninvasive procedure that provides
information on sympathetic and parasympathetic controls. Reduced HRV may indicate cardiac autonomic
dysfunction and susceptibility to hemodynamic instability during anesthesia, after myocardial infarction or
cardiac operations. Aim: This study was designed to investigate the effects of cardiopulmonary bypass on HRV
variability in children with congenital heart disease and if HRV is turning to the normal in postoperative
period and when, as well as the duration of the process. Methods: HRV data were obtained from 29 pediatric
patients with congenital heart disease, who underwent elective cardiac surgery. Electrocardiographic data were
collected with PC-based ECG acquisition system (PC-ECG 1200). ECG results were obtained by assessing 200
heart beats that recorded in supine position. Clinical data including age, type of cardiac lesion, type of surgical
procedure, cardiopulmonary bypass (CPB) time, cross clamp time were recorded. Results: 16 male and 13 female
patients mean aged 8.08±3.8 (1-15), 27 had an acyanotic heart disease, 2 of them had a cyanotic heart disease.
Standard deviation of all normal RR intervals (SDNN) (p=0.048) and HRV triangular index (p=0.017) were
significantly lower in the postoperative first month than preoperatively. There were no significant preoperative
differences in other time or frequency domain measures of HRV between the preoperative recordings and postoperative
for the first month. SDNN, low and high frequency were found significantly low when compared between the
postoperative first and third month, although HF was decreased in the first postoperative month, but did not reach
statistical significance. Conclusion: Our findings showed that decreased HRV is a nonspecific marker of cardiovascular
stress just after the cardiac operations, reflecting an alteration in autonomic nervous system input to the heart and
turning to the normal in the third month.
Cardiopulmonary bypass, heart rate variability, spectral analysis
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Introduction
Heart rate variability (HRV), which reflects
autonomic nervous system activity, is useful for
assessing autonomic control under various physiologic
and clinical conditions.1 Spectrum analysis of HRV is a
noninvasive procedure that provides quantitative
information on sympathetic and parasympathetic
controls. Reduced HRV may indicate cardiac autonomic
dysfunction and susceptibility to hemodynamic
instability during anesthesia, after myocardial infarction
or cardiac operations.2-4
Reduced HRV has been observed in patients
before and after operations of the congenital heart
disease.5 Previous studies have mainly demonstrated
HRV changes between preoperative and postoperative
values. Little is known about course of HRV after the
open heart operations for congenital heart disease.
Consequently, the aim of this study was to investigate
the effects of cardiopulmonary bypass on HRV
variability in children with congenital heart disease and
if HRV is turning to the normal in postoperative period,
as well as the duration of the process.

were recorded for all patients. Postoperative data
included duration of mechanical ventilation, inotropic
support, pleural drainage, and hospitalization period.
The anesthesia and surgical management of all
patients were performed same manner. Anesthesia was
induced and maintained with ketamine hydrochloride
(Ketalar; EWL Eczac ba Warner Lambert IstanbulTurkey) and Fentanyl (Fentanyl Citrate ; Abbott
Laboratories, USA). After surgery, all patients were
admitted to the intensive care unit (ICU) and ventilated
mechanically. Patients received routine postoperative
care, including administration of analgesic as needed
for pain relief, and dopamine for cardiac support if
necessary. When cardiopulmonary function was stable,
the patients were transferred to the ward. Patients
receiving cardiovascular medications (beta-blockers,
digoxin, and calcium antagonists) in postoperative
follow-up were excluded from the study. Measurements
were obtained on the preoperative day and in
postoperative months 1 and 3. All HRV measurements
were taken in the afternoon (2:00-6:00 PM) to avoid
influences of night/day differences.

Heart Rate Variability
Patients and Methods
HRV data were obtained from 29 consecutive
pediatric patients with congenital heart disease, who
underwent elective cardiac surgery. Informed consent
from the patient's parents was taken before surgery to
participate in the study. Exclusion criteria included:
a) Patients with arrhythmia or pacemaker; b) Weight
less than 6 kg; c) Preoperative instable clinical
conditions; d) Preoperative cardiovascular medications.
Clinical data including age, type of cardiac lesion,
preoperative medications, type of surgical procedure,
cardiopulmonary bypass (CPB) time, cross clamp time

41

Electrocardiographic data were collected with
PC-based ECG acquisition system (PC-ECG 1200;
NORAV Medical Ltd. Yokneam, Iceland). ECG results
were obtained by assessing 200 heart beats that recorded
in supine position. HRV parameters were assessed with
careful attention given to the rhythm in order to be sure
that patient was in sinus rhythm, and all of the marked
QRS complexes were controlled. Mistakenly marked
artifacts were corrected manually. For ECG recordings
in which more than 10% had artifacts, the process was
repeated.
A short period analysis of HRV was performed
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for both the frequency and time domain parameters by
using PC-based ECG acquisition system (PC-ECG
1200) that allows automatic measurements.

Heart Rate Variability Analysis
HRV measurement is based on the sequence of
RR intervals. SDNN is the standard deviation of all
normal RR intervals (those measured between
consecutive sinus beats). HRV indices described above
are measures of variability in RR interval.7 Among time
domain parameters; SDNN and HRV triangular index
were measured separately.
HRV may similarly be broken into the frequency
components that compose the overall variability.
Frequency domain analysis is performed by taking a
series of numbers along the axis and computing the
Fourier transform.6 Akselrod et al showed that low
frequency (LF) band (0.04-0.15 Hz) is related to both
sympathetic and parasympathetic modulation, and the
high frequency (HF) band (0.15-0.40 Hz) is related to
parasympathetic effects. The ratio of LF to HF power
is often used as a metric of sympathetic-parasympathetic
balance. 7 Low frequency and high frequency
components of frequency domain parameters were also
measured and LF/HF ratio was determined manually.

Statistical Methods
Descriptive statistics were given as mean±SD
(Standard Deviation). Paired and unpaired Student's
t tests were used for normally distributed data and
Spearman analysis was used to establish correlations
using the statistical package SPSS-10.0 for Windows.
P value less than 0.05 was regarded as significant.

Results

heart disease (Tetrology of fallot). None of the patients
required any medications in the postoperative followup. Baseline HRV recordings were noted for seven days
prior to the elective surgery. There was no operative or
postoperative mortality. Sinusal tachycardia was
encountered in two patients because of hypovolemia in
the first hours of postoperative period and turned to
normal with fluid and blood replacement. Low dose
inotropic (dopamine 3 mcg/kg/min) support was
required in 7 patients at the first two hours. Other
operative data and postoperative data of all patients were
shown in Table 1.
There was any significant difference between the
heart rates of preoperative, postoperative first and third
month (104±17, 106±20 and 103±20 respectively,
p>0.05). Postoperative HRV recordings were obtained
in one and three month period after surgery (Table 2).
For all patients, SDNN (p=0.048) and HRV triangular
index (p=0.017) were significantly lower in the
postoperative first month than preoperatively (Figure 1).
The magnitude of decrease was greater for HF than for
LF power, resulting in a significantly (p=0.01) increase
in LF/HF ratio (Figure 2). Mean RR values of third
month were found significantly increased in order to
preoperative and first month values (Table 2). There
were no significant preoperative differences in other
time or frequency domain measures of HRV between
the preoperative recordings and postoperative for the
first month.
SDNN (p=0.05) and LF (p=0.05) found
significantly low when compared between the
postoperative first and third month (Figure 3), although
Table 1. Operative and postoperative patient data
Patient data
(n=29)
Cardiopulmonary bypass time (min)

58.6±35.4

Cross clamp time (min)

37.34±30.1

Duration of ventilation (hour)
Gender of the patients was 16 male and 13 female
and their mean age was 8.08±3.8 (1-15). Twenty-seven
had an acyanotic heart disease (15 ventricular septal
defects, 12 atrial septal defects), 2 of them had a cyanotic
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Number of patients with inotropic support
Postoperative bleeding (ml)

4.18±2.0
7
90±123

Mean±SD
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SDNN0: preoperative value of standard deviation of normal
RR intervals
SDNN1: postoperative first month value of standard deviation
of normal RR intervals
HRV0: preoperative value of Heart Rate Variability
HRV1: postoperative first month value of Heart Rate Variability

LF: Low frequency
HF: High frequency
LF/HF: Ratio

Figure 2. Comparison of LF, HF and LF/HF between
preoperative and postoperative first month.

Figure 1. Comparison of SDNN and HRV between
preoperative and postoperative first month.

Table 2. Time related changes in HRV
Preoperative

1 month

3 month

P1

P2

P3

593±16

598±32

685±32

0.1

0.002

0.007

SDNN (ms)

24,91±2,4

24,33±5,7

32,8±7,4

0.048

0.04

0.05

RMSSD (ms)

22,31±4,1

22,9±10

35,85±13,1

0.09

0.55

0.01

HRV triangular index

7,7±0,65

7,4±1,1

8,0±0,69

0.017

0.60

0.58

LF

303,6±44,1

244,4±37,3

186,79±22,1

0.64

0.69

0.05

HF

201,3±31,34

161,03±31,3

255,4±33,3

0.13

0.13

0.09

1,69±0,29

3,4±1,5

1,3±0,6

0.012

0.64

0.26

Mean RR

LF/HF

Mean±SD
P1: P value of preopertive and first month comparison.
P2: P value of preopertive and third month comparison.
P3: P value of first and third month comparison.
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SDNN1: postoperative first month value of standard
deviation of normal RR intervals
SDNN3: postoperative third month value of standard
deviation of normal RR intervals
LF1: Low frequency value of first month
LF3: Low frequency value of third month

Figure 3. Comparison of SDNN and LF between
postoperative first and third months.

other parameters were decreased in the first
postoperative month, these did not reach statistical
significance.
Significant statistical changes of all HRV
parameters could not be found significant between
preoperative and postoperative third month recordings.
Correlation analysis between HRV parameters and
cardiopulmonary bypass and cross clamp time did not
show any significance. Effect of other operative
parameters including ventilation time, volume of the
postoperative bleeding and inotropic support could not
be found significant.

Discussion
CPB was introduced during the 1950's and has
since then been used extensively in congenital cardiac

J HK Coll Cardiol, Vol 17

operations. Despite its extensive use, CPB has been
associated various problems such as cardiac
dysfunction, electrolyte disturbances, catecholamine
stimulation, irritative scar and sutures in the
myocardium, residual hemodynamic impairment, as
well as pain and anxiety.8 These and other unknown
factors, may effect HRV.
There have been limited reports on HRV in
pediatric patients with congenital heart disease before
and after cardiopulmonary bypass. In the first study,
Heragu and Scott found reduced HRV in acyanotic
and cyanotic patients postoperatively.4 Similar to this
study, recordings of patients operated for tetralogy
of Fallot particularly with ventricular arrhythmia
showed reduced HRV.5 Kaltman et al evaluated only
frequency domain HRV analysis in neonates with
single ventricle and two ventricles physiology,
despite early difference after cardiac surgery, HRV
indices become indistinguishable between two groups
by 3-6 months of age. 9 In our study, reduced HRV
was found in first month according to preoperative
measurements (Figure 1).
We know from the literature that measures of
HRV is changing with the age and Heragu and Scott
measured HRV in healthy controls and found that
time domain measures of HRV increase with age
throughout the pediatric age range, achieving adult
values by adolescence and also found that the quotient
of SDNN and mean RR intervals tended to remain
stable across most of the pediatric age range.4 Their
findings were similar to those of Massin and von
Bernuth.10 In our study, spectral indices of HRV were
measured in different congenital cardiac defects and
compared with same patient before and after
cardiopulmonary bypass, therefore, we were not able
to commend on the effect of age.
LF/HF ratio is an indirect indicator of
sympathetic − parasympathetic balance.7 Significant
change in the LF/HF ratio of our patients were
explained as an operative stress and sympathetic
hyperactivity in the first month and turned to
preoperative values in the third month measurement,
so any significant change could not be found between
preoperative and third month measurements.
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Significant changes were found in parameters
mean RR, SDNN between the first and third month.
These results in the postoperative period suggest that
further parasympathetic withdrawal is an important
component of these changes. This could partly be the
result of decreased sensitivity of the sinus node to
autonomic nervous input immediately after surgery
for congenital heart disease. Heragu and Scott found
similar results in their study.4
Type of cardiac lesion, preoperative medications,
type of surgical procedure, cardiopulmonary bypass
time, cross clamp time, did not correlate with the HRV
recordings because of our homogenous and small
patient group but in the literature Gordon et al
demonstrated in a heterogeneous population of
congenital heart patients that decreased LF and
decreased LF/HF ratio, in the postoperative time
period, which was associated with cardiac arrest.
These reduced spectral indices were postulated to
represent a diminished capacity for cardiac
autonomic control.11

Conclusion
Our findings showed that decreased HRV is a
nonspecific marker of cardiovascular stress just after
the cardiac operations, reflecting an alteration in
autonomic nervous system input to the heart and
turning to the normal in the third month.
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ICSM, THE THIRTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Invited Lectures:
IL1.
E N D OT H E L I A L DY S F U N C T I O N : T H E C O M M O N
CONSEQUENCE IN DIABETES AND HYPERTENSION
Y Huang
Institute of Vascular Medicine & School of Biomedical Sciences, The Chinese
University of Hong Kong, Hong Kong

dependent relaxation, induce endothelium-dependent contraction, and cause
endothelial cell apoptosis. Importantly, we found a crosstalk between the
RAS and BMP4 in hypertension and diabetes. Better understanding of the
cellular and molecular mechanisms of endothelial dysfunction shall help to
identify more effective therapies to improve cardiovascular outcomes in
patients with hypertensive and diabetes.

Endothelial dysfunction, caused by diminished impact of endotheliumderived relaxing factors and/or exaggerated influence of endothelium-derived
contracting factors in the vascular wall, is the common consequence of
diabetes and hypertension. The degree of endothelial dysfunction predicts
future cardiovascular outcomes. We have examined the cellular mechanisms
involved in endothelial dysfunction in diabetes and hypertension using
ex vivo and in vivo models. We have identified an upregulation of reninangiotensin system (RAS) components in both hypertension and diabetes.
Our data show that the use of RAS blockers (including renin inhibitor, ARB
and ACE inhibitors) effectively restores endothelial function in both animal
models of diabetes and hypertension. Likewise, cyclooxygenase-2 (COX2) is also implicated to be a critical player in endothelial dysfunction in
both pathological conditions. Both RAS and COX mediate the detrimental
effects of several risk factors on endothelium-dependent relaxations in mouse
and rat arteries, including hyperglycemia, oxidative stress, inflammatory
cytokines, angiotensin II, and advanced glycation end products. Recently,
we have found that bone morphogenetic protein 4 (BMP4) is possibly one
of the common upstream activators to induce endothelial dysfunction in
both hypertension and diabetes. BMP4 activated NAD(P)H oxidases to
induce oxidative stress and upregulated the expression and activity of COX2 in endothelial cells, which could cause hypertension, impair endothelium-

IL2.
VASCULAR OXIDATIVE STRESS: THE COMMON LINK
RA Cohen, XY Tong
Vascular Biology Unit, Whitaker Cardiovascular Institute, Boston University
School of Medicine, USA
Vascular disease in hypertension and diabetes is associated with systemic
vascular inflammation and increased adhesion of leukocytes to activated
vascular cells. Excess levels of oxidants are implicated both as a cause of
damage to vascular constituents, but also as important pathogenic contributors
to changes in cardiovascular cell structure and function. The excess oxidants
arise from several sources including NADPH oxidase, xanthine oxidase, and
mitochondria. Superoxide anion and hydrogen peroxide are produced by these
systems in both leukocytes and vascular cells, and hypochlorous acid, another
strong oxidant, is produced by leukocyte myeloperoxidase. Nitric oxide is
also produced in excess by the inducible isoform of nitric oxide synthase in
inflamed blood vessels. Peroxynitrite, formed by the rapid reaction of
superoxide and nitric oxide, is another potent endogenous oxidant in
hypertensive and diabetic human and animal blood vessels. These oxidants
cause damage, altering protein function, introducing DNA mutations, and
increasing lipid peroxidation. Unlike that to DNA and lipids, the damage to
proteins is selective, affecting specific oxidant-sensitive cysteine, tyrosine,
methionine, and tryptophan amino acid residues. Altered structure and function
of some proteins results, and if the oxidation is irreversible, then protein
degradation is required for restoration of function. With some important
vascular proteins, for example endothelial nitric oxide synthase, prostacyclin
synthase, and superoxide dismutase, oxidation of a single susceptible amino
acid inactivates the enzyme. The beneficial effects of antioxidants, at least in
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animal models of hypertension and diabetes, can in part be ascribed to
protection of the function of these and other proteins. The pathogenic
importance of oxidation of specific cysteine residues is reflected by the fact
that in some proteins, such as the sarcoplasmic reticulum calcium ATPase,
expression of mutant proteins lacking the reactive cysteine thiol, recapitulates
a disease phenotype, such as accelerated smooth muscle or impaired endothelial
cell migration. Thus, many of the shared functional abnormalites of
hypertensive and diabetic blood vessels may be caused by oxidants. Although
studies using antioxidants have failed in patients, the successful treatment of
vascular disease with HMG CoA reductase inhibitors, PPAR agonists,
thromboxane A2 antagonists, and polyphenols may depend upon their ability
to decrease production of damaging oxidants.

October 2009

48

ICSM, THE THIRTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Invited Lectures:
IL3.

IL4.

THE TP-RECEPTOR: THE COMMON VILLAIN

THE HYPERTENSION-DIABETES CONTINUUM

M Félétou
Department of Angiology, Institut de Recherches Servier, 11 rue des
Moulineaux, Suresnes, France

BMY Cheung
Department of Medicine, The University of Hong Kong, Hong Kong

Thromboxane A2 is the preferential physiological ligand of the TP receptor
but other prostaglandins as well as some prostanoids, which do not
necessarily derived from cycooxygenases (COX) such as isprostanes, are
also able to activate this receptor. The stimulation of TP receptors elicits
diverse physiological/pathophysiological actions, including platelet
aggregation and smooth muscle contraction. Furthermore, the activation of
endothelial TP receptors promotes the expression of adhesion molecules
and favours adhesion and infiltration of monocytes/macrophages. In various
cardiovascular diseases, the endothelial dysfunction is due to the release of
endothelium-derived contracting factors (EDCF) that counteract the
vasodilator effect of NO. Endothelium-dependent contractions involve the
activation of COX, the production of reactive oxygen species along with
that of EDCFs, which diffuse toward the vascular smooth muscle cells and
activate the TP receptors. Antagonists of the TP receptor curtail the
endothelial dysfunction in diseases such as hypertension and diabetes, are
potent antithrombotic agents and prevent vascular inflammation. Therefore,
TP receptor antagonists, because of this triple activity, may demonstrate a
unique potential for the treatment of cardiovascular disorders.

Hypertension and diabetes are both common chronic conditions that affect
a major proportion of the general population. They tend to occur in the
same individual, suggesting common predisposing factors, which can be
genetic or environmental. While the genes causing hypertension or diabetes
await elucidation, the environmental causes of these diseases are well known.
Obesity and physical activity are the two leading factors that predispose to
both diseases. Individuals with abdominal obesity are likely to develop lipid
abnormalities and elevation of blood pressure and glucose. In time,
hypertension and diabetes ensue. Because of the shared aetiology, there is
substantial overlap between hypertension and diabetes. In the Hong Kong
Cardiovascular Risk Factor Prevalence Study, 40% of the subjects in the
community had either raised blood pressure or raised blood glucose. Only
42% of people with diabetes had normal blood pressure and only 52% of
people with hypertension had normal glucose tolerance. The presence of
hypertension or diabetes should alert the clinician to the possibility of the
other condition. Obesity, lipid abnormalities, raised blood pressure and
glucose are all components of the metabolic syndrome. The syndrome
therefore implies a pathological process, which is potentially reversible in
the early stages. Previous efforts targeting smoking, hypertension and
hypercholesterolaemia have started to bear fruit. However, obesity is on the
increase in developed and developing countries. It is now time to focus on
obesity and the metabolic syndrome, which require more a public health
than a pharmacological approach.

IL5.
IMPORTANCE OF BLOOD PRESSURE LOWERING IN TYPE
2 DIABETES
J Chalmers
The George Institute for International Health, University of Sydney, Australia
The main results of ADVANCE, published in 2007 indicated major benefits
of blood pressure lowering with the fixed combination of perindopril and
indapamide, which reduced mortality, cardiovascular complications and renal
disease, in patients with type 2 diabetes, irrespective of baseline blood pressure,
whether the patients were hypertensive or not.
The findings presented at this meeting will show that these findings are
remarkably consistent across a very wide spectrum of patients with type 2
diabetes. First we report that the renal benefits are similar in patients with
baseline systolic blood pressures ranging from above 160 to below 120 mmHg
at baseline. In absolute terms, the fixed combination of perindopril and
indapamide prevented one renal event among every 20 patients treated for 5
years.
Next we demonstrate that the benefits of this treatment are similar across age
groups, and that older patients over the age of 75 years derive at least as much
benefit as younger subjects, with greater reductions in absolute risk and no
significant increase in adverse events.

indapamide are similar across sub groups defined by cognitive function at
baseline.
We report that urinary albumin and estimated Glomerular Filtration Rate
(eGFR) are independent risk factors for cardiovascular and renal events in
patients with type 2 diabetes and that the benefits of blood pressure lowering
with perindopril-indapamide are at least as great or greater in patients with
renal disease at baseline.
Finally, we show that the benefits of blood pressure lowering with perindoprilindapamide are similar in all risk categories, but that the absolute risk reductions
are greater in patients with type 2 diabetes with the highest initial risk as
categorized according to the 2007 ESH/ESC guidelines.
In conclusion, extensive studies of the effects of blood pressure lowering the
fixed dose combination of with perindopril and indapamide confirm the
remarkable consistency of benefits obtained in a very broad cross section of
patients with type 2 diabetes. This suggests the results are applicable to
community patients with diabetes and strengthens the recommendation that
this treatment with this treatment should be considered routinely for the
prevention of serious complication in patients with type 2 diabetes across the
world.

Our findings demonstrate that cognitive function at entry is an independent
predictor of clinical outcomes in patients with type 2 diabetes, but that the
reductions in mortality and clinical complications obtained with perindopril-
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NOX4 IS A NOVEL SOURCE OF INTRACELLULAR ROS
REQUIRED FOR OXIDIZED LDL-INDUCED MACROPHAGE
DEATH
CF Lee,1 M Qiao,2 R Asmis1,2
1
Department of Biochemistry, 2Department of Clinical Laboratory Sciences,
School of Health Professions; the University of Texas Health Science Center
at San Antonio, San Antonio, Texas 78229, USA
An elevated plasma level of oxidized low density lipoproteins (OxLDL) is a
biomarker for cardiovascular diseases including atherosclerosis. OxLDL
promotes macrophage death, a hallmark of atherosclerotic lesions. In human
monocyte-derived macrophages (HMDM), OxLDL increases intracellular ROS
formation, which is absolutely required for OxLDL cytotoxicity (Asmis et al,
Circ. Res. 2003; Wang et al., FRBM, 2006). However, the source of these
ROS was not known. We now identified a new member of the Nox family,
Nox4, in HMDM, and hypothesized that Nox4 mediates OxLDL-induced ROS
formation and macrophage death. We found that in HMDM OxLDL upregulated Nox4 mRNA expression but not Nox1, 2, 3 or 5 mRNA. OxLDL
concomitantly up-regulated Nox4 and p22 phox protein levels. Confocal
microscopy studies showed that Nox4 appears to co-localize with p22phox.
Co-immunoprecipitation confirmed the association between p22phox and Nox4,
suggesting that an active Nox4/p22phox complex is present in HMDM. Inhibition
of MEK but not p38-MAPK or JNK prevented the up-regulation of Nox4
induced by OxLDL. Inhibition of MEK also prevented the OxLDL-induced
increase in ROS formation and protected HMDM from OxLDL-mediated cell
death, suggesting that Nox4 mediates both ROS formation and cell death
induced by OxLDL. In contrast, inhibitors of p38-MAPK or JNK did not

block OxLDL-induced ROS formation, and showed no protection against
OxLDL. To confirm a mechanistic link between OxLDL-induced Nox4/p22phox
induction, ROS production and macrophage death, we used gene silencing
and over-expression approaches. Adenovirus-delivered siRNA directed against
Nox4 suppressed OxLDL-induced ROS formation and macrophage death while
ectopic Nox4 expression enhanced ROS formation and accelerated macrophage
death induced by OxLDL. In summary, we demonstrate that the Nox4/p22phox
complex is induced in HMDM in response to OxLDL stimulation via the
MEK/ERK pathway. In conclusion, Nox4 mediates OxLDL-induced ROS
formation and macrophage death, implicating monocytic Nox4 in the
development and progression of atherosclerotic lesions.

OC2.
MATRIX METALLOPROTEINASE-9 (MMP-9) DELETION
SLOWS CARDIAC AGING
YA Chiao,1 R Zamilpa,2 Q Dai,2 M Montes,2 ML Lindsey2
Department of Biochemistry, 2Department of Medicine, the University of
Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA

1

Cardiac aging is associated with decreased function of the left ventricle
(LV) and higher prevalence of cardiovascular disease, but the mechanisms
of cardiac aging are not fully understood. We have shown that matrix
metalloproteinase-9 (MMP-9) regulates cardiac remodeling after myocardial
infarction (MI), and LV MMP-9 levels increase from middle-aged to old
mice. Accordingly, we tested the hypothesis that the age-related increase in
MMP-9 regulates cardiac aging. We compared young (4-8 month old) and
old (18-23 month old) wild type (WT) and MMP-9 null mice. For both WT
and MMP-9 null mice, no increases in blood pressure were observed with
age. By Doppler echocardiography, old WT mice showed lower early
diastolic filling to atrial filling (E/A) ratios compared with young WT mice,
indicating diastolic dysfunction with age. In contrast, old MMP-9 null mice
showed similar E/A ratios as young WT and young null mice, suggesting
that MMP-9 deletion preserves diastolic function with age. In addition, picrosirius red (PSR) staining showed increased perivascular collagen in WT LV
with age, while old MMP-9 null mice appeared to have less perivascular
collagen deposition. Together, these data suggest that blocking MMP-9
function may slow cardiac aging in mice.

J HK Coll Cardiol, Vol 17
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TOLL-LIKE RECEPTOR 4 DEFICIENCY ATTENUATES
I N S U L I N R E S I S TA N C E A N D E N D O T H E L I A L
DYSFUNCTION ASSOCIATED WITH OBESITY AND
DIABETES IN MICE
CF Liang1, A Xu,1,2 PM Vanhoutte1
1
Department of Pharmacology and Pharmacy; 2Department of Medicine,
The University of Hong Kong, Hong Kong
Background: Aging and obesity are major risk factors for endothelial
dysfunction and metabolic syndrome. Endothelial dysfunction is
characterized by an impaired release of endothelium-derived relaxing
(EDRF) and hyperpolarizing (EDHF) factors and enhanced production of
contracting factors (EDCF). The Toll-like receptor 4 (TLR4) is a major target
for lipopolysaccharide and saturated fatty acids, both of which are potent
inducers of inflammation and insulin resistance. The present study was
designed to evaluate the role of TLR4 in modulating metabolism and
endothelial function in mice with loss-of-function mutation of TLR4.
Methods: TLR4 -/- (C3H/HeJ) and wild type (C3H/HeOuJ) mice were
subjected to standard or high fat diet. A type-2 diabetes animal model, double
knockout in leptin receptor (Lepr) and TLR4 (DKO), was obtained by
crossing Leprdb/+ and TLR4-/- mice. Glucose and insulin tolerance tests (GTT
and ITT) were carried out. Systolic blood pressure was measured by tailcuff method. The animals were sacrificed at the age of 12 weeks. Rings of
aorta, carotid artery and mesenteric artery (with or without endothelium)
were suspended in a wire-myograph for measuring changes in isometric
tension. Endothelial function was assessed by recording the responses to
endothelium-dependent vasodilator and vasoconstrictor agonists.

Results: TLR4-/- mice under high fat diet feeding showed a better insulin
sensitivity and lower blood pressure than wild type mice. DKO mice also
demonstrated a significantly lower fasting blood glucose, serum cholesterol,
lower blood pressureand better insulin sensitivity than Leprdb/db control mice.
Acetylcholine-induced EDCF-mediated responses in carotid arteries were
enhanced by aging, high fat diet, and genetic obesity, but were significantly
attenuated by TLR4 deficiency. The contractions were inhibited by
indomethacin, SC560, and S18886, but not NS398, suggesting the
involvement of COX-1. Apocynin, MnTMPyP, catalase but not deferoxamine
also inhibited the contractions, suggesting that reactive oxygen species may
play a role. Acetylcholine-evoked hyperpolarizations were estimated in
mesenteric arteries as endothelium-dependent relaxations blocked by Tram34 and UCL-1684. The acetylcholine-induced EDHF responses were
potentiated in TLR4 -/- mice fed with control and high fat diet. The
acetylcholine and sodium nitroprusside-induced relaxations in the aorta were
not different in wild type and TLR4-/- mice.
Conclusion: Toll-like receptor 4 deficiency can prevent aging and obesityinduced insulin resistance and endothelial dysfunction possibly by decreasing
oxidative stress.

OC4.
ENHANCEMENT OF ENDOTHELIAL NITRIC OXIDE
SYNTHASE PREVENTS ENDOTHELIAL DYSFUNCTION
INDUCED BY ASYMMETRICAL DIMETHYLARGININE
HM Xue, JH Huang, GW He, Q Yang
Department of Surgery, The Chinese University of Hong Kong, Hong Kong
Background & Objectives: Asymmetrical dimethylarginine (ADMA) is an
endogenous L-arginine analogue that may competitively inhibit nitric oxide
synthase (NOS). A growing body of evidence suggests the association
between an elevated plasma level of ADMA and endothelial dysfunction.
ADMA is now recognized as a risk factor for several cardiovascular diseases,
such as hypertension and coronary artery disease. In the present study, we
investigated the efficacy and mechanisms of AVE3085, a newly developed
transcription enhancer of endothelial NOS (eNOS), with regard to its
protection against ADMA-induced coronary endothelial dysfunction.
Methods: Porcine coronary small arteries (diameter 600 to 800 µm) were
studied in a myograph for bradykinin (-10~-6.5 Log M)-induced,
endothelium-dependent relaxation as well as endothelium-independent
relaxation to sodium nitroprusside (-11~-4.5 Log M). Western blot
experiments were performed to determine the protein expression of eNOS
and the phosphorylation of eNOS at serine 1177 (p-eNOS Ser1177) and at
threonine 495 (p-eNOSThr495). The expression of nitrotyrosine was examined
as well.
Results: Pre-incubation with ADMA (50 µM) for 1-hr significantly decreased
the vasorelaxation of coronary arteries to bradykinin but not the relaxation
to sodium nitroprusside. The maximal response to bradykinin decreased
from 92.2±2.6 to 61.3±4.7 (p<0.05) and EC50 left shifted from 7.80±0.14
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to 7.04±0.16 (p<0.01). Co-incubation with AVE3085 preserved bradykinininduced vasorelaxation (94.6±1.6 vs. 86.7±3.2, p>0.05). ADMA markedly
reduced the protein expressions of eNOS and p-eNOSSer1177 whereas increased
the expressions of p-eNOSThr495 and nitrotyrosine (p<0.05). The decreased
expression of eNOS and eNOS phosphorylation at serine 1177 was reversed
by AVE3085. The increased expression of p-eNOSThr495 and nitrotyrosine
was however, lowered by AVE3085 treatment (p<0.05).
Conclusions: AVE3085 protects against ADMA-induced endothelial
dysfunction in coronary arteries. Enhancement of eNOS expression and
activation as well as reduction of oxidative stress may account for the
protective effect of AVE3085.
Acknowledgments: This study was supported by Hong Kong RGC grant
(CUHK4651/07M) and CUHK direct grants 2041388 & 2041384.
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POLYOL PATHWAY CONTRIBUTES TO THE ACUTE
H Y P E R G LY C E M I A - I N D U C E D C O N T R A C T I L E
DYSFUNCTION IN PERFUSED HEART FROM RAT
WH Tang,1 WT Cheng,1 GM Kravtsov,1 SK Chung,2 SSM Chung1
Department of Physiology and 2Department of Anatomy, Faculty of Medicine,
The University of Hong Kong, Hong Kong

1

the activation is probably contributed by reactive oxygen species. All these
abnormalities were significantly attenuated by treatment with ARI or SDI.
Thus, during acute hyperglycemia, polyol pathway-induced depletion of
glutathione and increased level of superoxide probably inactivate SERCA,
and stimulate NCX, leading to the abnormalities in contractile function.

The polyol pathway, consisting of aldose reductase (AR) and sorbitol
dehydrogenase (SDH), is an alternate metabolic route that converts excess
glucose to fructose. It has been implicated in the development of various
diabetic complications including nephropathy, retinopathy and cardiovascular
disease. Previously, inhibition of AR was found to protect diabetic mice hearts
from contractile dysfunction, suggesting that the polyol pathway contributes
to hyperglycemia-induced contractile dysfunction. In this report we show that
this glucose metabolic shunt also contributes to acute hyperglycemia-induced
cardiac contractile dysfunction. Rat hearts were isolated and retrogradely
perfused with either Krebs' buffer containing 10 µM AR inhibitor, Fidarestat,
or 1 µM SDH inhibitor, CP-170,711, and subjected to acute hyperglycemia
by perfusing with high glucose medium (33.3 mM) for 2 hours. The polyol
pathway activity was measured by high performance liquid chromatography.
Changes in the oxidative stress were determined by biochemical assays. We
find that acute hyperglycemia-induced contractile dysfunction of the isolated
perfused hearts is improved by pharmacological inhibition of the polyol
pathway. The acute hyperglycemia-induced contractile dysfunction is most
likely contributed by the changes in the activities of sacro/endoplasmic
reticulum Ca2+-ATPase (SERCA) and sodium calcium exchanger (NCX), two
key players in Ca 2+ regulation. Under acute hyperglycemia, SERCA is
inactivated by the tyrosine nitration, which is contributed by high level of
peroxynitrite. However, the activity of NCX is significantly increased, and

OC6.
PROTECTIVE EFFECTS OF GINSENOSIDES AGAINST
ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC MICE
WT Wong,1 XY Tian,1 FP Leung,1 AM Xu,2 ZH Jiang,3 RNS Wong,4 Y Huang1
Institute of Vascular Medicine and School of Biomedical Sciences, The
Chinese University of Hong Kong; 2Department of Medicine and Department
of Pharmacology & Pharmacy, The University of Hong Kong; 3School of
Chinese Medicine; 4Department of Biology, Hong Kong Baptist University,
Hong Kong

1

Diabetes is associated with endothelial dysfunction which contributes to
the increased cardiovascular risks. The present study investigated whether
or not ginseng extracts (PPD- or PPT-type ginsenosides) could restore
endothelial function in the lepr-/- db/db mouse and the possible underlying
cellular mechanisms. Db/db mice of 12-week-old were treated with PPD- or
PPT-type ginsenosides (20 mg/kg/day) and vehicle for 14 days. Oral glucose
tolerance test was performed after chronic administration of ginsenosides.
Vascular function was assessed in aortas and femoral arteries. The expression
of total and phosphorylation form of AMP-activated protein kinases (AMPK)
and endothelial nitric oxide synthase (eNOS) were detected by Western
blotting method. The present results show that PPD-type but not PPT-type
ginsenosides improved oral glucose tolerance in db/db mice. Endotheliumdependent relaxations induced by acetylcholine were markedly impaired in
diabetic mice and rescued by chronic treatment with PPD- or PPT-type
ginsenosides. Acute inhibition of AMPK by compound C prevented the
improvement of acetylcholine-induced relaxations in aortas and femoral
arteries of PPD-treated but not PPT-treated db/db mice. Western blot analysis
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revealed that PPD increased the phosphorylation of AMPK and eNOS in
db/db mouse aortas without affecting the total amount of AMPK or eNOS.
PPT did not change the protein expression of AMPK phosphorylation. The
present findings demonstrate that consumption of PPD- and PPT-type
ginsenosides reverses endothelial dysfunction in diabetic mice. More
importantly, PPD-type ginsenosides increase nitric oxide bioavailability
through the increased phosphorylation of AMPK. These vasoprotective
effects may account for a significant reduction of cardiovascular events in
type 2 diabetic patients who receive ginsenoside therapy. (Supported by
GRF/465308 and HKBU1/06C).

October 2009

52

ICSM, THE THIRTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Oral Communications:
OC7.
BINDING OF GENISTEIN WITH MEMBRANE ESTROGEN
RECEPTOR AND THE POTENTIATING EFFECT OF
GENISTEIN IN RAPID, NON-GENOMIC VASCULAR
ACTION
AHY Lin, GPH Leung, SWS Leung, RYK Man
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong

Conclusion: The tissue bath studies demonstrate that rapid potentiating effect
of genistein in acetylcholine-induced relaxation is non-genomic and G
protein-coupled. In addition, our data also suggests that genistein may bind
to nuclear and membranous estrogen receptors. Further studies are required
to reveal whether the non-genomic vascular effect of genistein is mediated
through the membranous estrogen receptors.

Background: Genistein is a phytoestrogen which enhances endothelial
functions in a receptor-mediated manner. The present study was designed
to characterize the mechanism involved in the rapid vascular actions of
genistein and to determine whether genistein share the same receptor with
estrogen in its non-genomic action.
Methods: Using tissue bath studies, isometric tension was measured in aortic
rings isolated from 32-week-old male spontaneously hypertensive rats. The
nuclear and membranous isoforms of estrogen receptor (ER)-α, ER-α66
and ER-α46, were cloned and expressed using a cell-free expression system.
Binding study was performed subsequently.
Results: Genistein acutely potentiated acetylcholine-induced relaxation. This
effect was insensitive to the transcription and translation inhibitors,
actinomycin D and cycloheximide, respectively. The potentiation of
acetylcholine and A23187-induced relaxation by genistein was inhibited by
NF023 and GP antagonist-2A, the selective Gi and Gq α-subunit antagonists,
respectively, but not by NF449, a selective G s α-subunit antagonist.
ER-α66 and ER-α46 were successfully cloned and expressed in vitro, with
molecular sizes confirmed by Western blotting. 17β-estradiol bound to the
ER-α66 and ER-α46 with similar affinity and genistein competed with
17β-estradiol for binding to both receptors.

OC8.
CHRONIC TREATMENT OF VITAMIN D DERIVATIVES
REDUCE ENDOTHELIUM-DEPENDENT CONTRACTIONS
IN THE AORTA OF THE SPONTANEOUSLY HYPERTENSIVE
RAT
MSK Wong, RYK Man, PM Vanhoutte
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong

and treated groups. COX-1 mRNA level was significantly inhibited in the
treated SHR. These results demonstrate that chronic treatment of 1,25dihydroxyvitamin D3 modulates vascular tone by inhibiting the expression
level of COX-1 mRNA which is a completely different mechanism as in the
acute treatment. This chronic effect to EDCF may account for one of the
factors that reducing the mean arterial blood pressure in the SHR rats.

The available evidences suggest that vitamin D has cardiovascular effects
besides regulating calcium homeostasis. Previous studies demonstrated that
1,25-dihydroxyvitamin D3, the major metabolite of vitamin D, acutely reduce
endothelium-dependent contractions induced by acetylcholine. To examine
the chronic effect of 1,25-dihydroxyvitamin D3, rats were treated with the
vitamin D derivative for 6 weeks. The serum 1,25-dihydroxyvitamin D3 level
was significantly higher than the control while the mean arterial blood
pressure was significantly lower. Aortic rings with or without endothelium
were used for organ bath experiments. The release of prostacyclin and
thromboxane A2 after acetylcholine or A23187 stimulation were measured.
The cytosolic-free calcium concentration was measured by confocal
microscopy with the fluorescent dyes Fluo-4. Real time PCR was used to
compare the mRNA level of COX-1, prostacyclin synthase, thromboxane
synthase and eNOS between the control and treated groups. Both
acetylcholine- and A23187-induced endothelium-dependent contractions
were reduced significantly in the treated group. The acetylcholine-induced
release of prostacyclin and the A23187-induced thromboxane A2 was reduced
in the treated group. There was no significant difference in cytosolic free
calcium concentration caused by acetylcholine or A23187 between control
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LUTEOLIN REDUCES CARDIAC DYSFUNCTIONS AND
M I T O C H R O N D R I A L O X I D AT I V E S T R E S S I N
STREPTOZOTOCIN-INDUCED DIABETIC RATS
F Su, HP Wang, Q Xia
Department of Physiology, Zhejiang University School of Medicine,
Hangzhou 310058, China
Aim: To investigate the effects of luteolin on cardiac functions and
mitochondrial oxidative stress in streptozotocin (STZ)-induced diabetic rats.
Methods: Male Sprague-Dawley rats were randomly divided into a normal
control group, a luteolin control group, a diabetic group, and diabetic groups
orally administered with a low dose (10 mg/kg/d) or a high dose of luteolin
(100 mg/kg/d) for eight weeks. The body weight, blood glucose, cardiac
functions, left ventricular weight, myocardial collagen, and reactive oxygen
species (ROS) levels were assayed. The cardiac mitochondrial ROS level,
superoxide dismutase (SOD) activity and the mitochondrial swelling were
measured.
Results: Treatment with luteolin had no effect on the blood glucose but
reduced the losing of body weight in diabetic rats. High dose of luteolin
markedly reduced the ratio of ventricular weight and body weight, increased
the left ventricular develop pressure, and decreased the left ventricular end
diastolic pressure in diabetic rats. The myocardial levels of ROS and collagen,
the cardiac mitochondrial ROS level, and the mitochondrial swelling in

diabetic rats were all markedly reduced by high dose of luteolin. Furthermore,
high dose of luteolin significantly increased the mitochondrial SOD activity
in diabetic rat hearts.
Conclusion: Treatment with luteolin for 8 weeks markedly improves the
cardiac function, which may be related to reducing mitochondrial oxidative
stress and mitochondrial swelling, in diabetic rats.
(This work was supported by grants from the National Natural Science
Foundation of Zhejiang Province (Y206179))

P2.
M AT E R N A L LY I N H E R I T E D H Y P E RT E N S I O N I S
ASSOCIATED WITH THE MITOCHONDRIAL tRNA Ile
A4295G MUTATION IN A CHINESE FAMILY
ZB Li,1 SW Wang,1 YQ Liu,1 Y Li,2 MX Guan2,3
Institute of Geriatric Cardiology, Chinese PLA General Hospital, Beijing,
China; 2Division of Human Genetics, Cincinnati Children's Hospital Medical
Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA; 3Department
of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH,
USA

1

Objective: Mutations in mitochondrial DNA have been associated with
cardiovascular disease. We report here the clinical, genetic, and molecular
characterization of one three-generation Han Chinese family with maternally
transmitted hypertension.
Methods: Members of this Chinese family underwent a physical
examination, laboratory assessment of cardiovascular disease risk factors,
and routine electrocardiography. Genomic DNA was isolated from whole
blood and the entire mitochondrial gene was amplified by PCR. PCR
fragments were purified and subsequently analyzed by direct sequencing
analysis.
Results: Sequence analysis of the complete mitochondrial DNA in this
pedigree revealed the presence of the known hypertension-associated tRNAIle
A4295G mutation and 33 other variants, belonging to the Asian haplogroup
D4j. The A4295G mutation, which is extraordinarily conserved from bacteria
to human mitochondria, is located at immediately 30 end to the anticodon,
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corresponding to conventional position 37 of tRNA Ile. The occurrence of
the A4295G mutation in several genetically unrelated pedigrees affected by
cardiovascular disease but the absence of 242 Chinese controls strongly
indicates that this mutation is involved in the pathogenesis of cardiovascular
disease. Of other variants, the tRNA Glu A14693G and ND1 G11696A
mutations were implicated to be associated with other mitochondrial
disorders. The A14693G mutation, which is a highly conserved nucleoside
at the TwC-loop of tRNAGlu, has been implicated to be important for tRNA
structure and function. Furthermore, the ND4 G11696A mutation was
associated with Leber's hereditary optic neuropathy.
Conclusion: The combination of the A4295G mutation in the tRNAIle gene
with the ND4 G11696A mutation and tRNA Glu A14693G mutation may
contribute to the high penetrance of hypertension in this Chinese family.
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VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) IS
INVOLVED IN APOPTOSIS OF CELL LINES CARRYING THE
MITOCHONDRIAL DNA A4263G MUTATION
YQ Liu, 1 L Gao, 1 Y Li, 1 ZB Li, 1 H Xu, 2 L Wang, 1 R Chen, 1 MH Liu, 1
Y Wen, 1 MX Guan,3 SW Wang1
1
Institute of Geriatric Cardiology, Chinese PLA General Hospital, Beijing,
China, 100853; 2Military Medical Science Academy of the Chinese PLA,
Beijing, China, 100850; 3Cincinnati Children's Hospital Medical Center,
Division of Human Genetics, Cincinnati, OH 45229, USA

were increased (P<0.05). The difference was attenuated by Cyclosporin A
(CsA, 2 µM), a blocker of VDAC. We conclude that increased expression of
mitochondrial VDAC and subcellular co-localization of VDAC/Bax increases
mitochondrial permeability and apoptosis in cell lines carrying the mtDNA
tRNAIle A4263G mutation.

The mitochondrial voltage-dependent anion channel (VDAC) is increasingly
implicated in the control of apoptosis. We have studied the effects the
mitochondrial DNA (mtDNA) A4263G tRNA Ile mutation on VDAC
expression, localization, and apoptosis. Lymphoblastoid cell lines were
derived from 3 symptomatic and 1 asymptomatic members of a family with
hypertension associated with the A4263G tRNAIle mutation as well as from
control subjects. Mitochondrial potential (∆Ψm) and apoptosis were measured
by flow cytometry; co-localization of VDAC and Bax was evaluated by
confocal microscopy. Expression of VDAC and Bax in mtDNA A4263G
cell lines was found to be increased compared to controls, while expression
of the small conductance calcium-dependant potassium channel (sKCa) was
unchanged. Confocal imaging revealed co-localization of VDAC/Bax on
the outer mitochondrial membrane of A4263G cell lines but not from
controls. Flow cytometry indicated that the mitochondrial potential was
decreased by 32% in A4263G cells versus controls while rates of apoptosis

P4.
THE ROLE OF PPAR-GAMMA IN TELMISARTAN-INDUCED
INHIBITION OF CONTRACTIONS IN MOUSE MESENTERIC
RESISTANCE ARTERIES
CY Yuen, WT Wong, XY Tian, J Yu, B Tomlinson, X Yao, Y Huang
School of Biomedical Sciences, Institute of Vascular Medicine and Department
of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong
Kong
Upon the activation of renin-angiotensin system (RAS), angiotensin II
stimulates the angiotensin II type 1 (AT1) receptor through triggering NAD
(P)H oxidase to produce superoxide anions, also referred as reactive oxygen
species (ROS) in vascular cells. The elevated level of ROS dramatically
reduces the bioavailability of nitric oxide (NO), leading to endothelial
dysfunction. Recently, telmisartan has been suggested to possess a partial
peroxisome proliferator-activated receptor-γ (PPAR-γ) activity in addition
to being a general angiotensin II-receptor blocker (ARB). Since the studies
of the role of PPAR-γ in telmisartan have been vastly lacking in blood vessels,
the present study is to examine the hypothesis that telmisartan-induced
inhibition of agonist-elicited contractions in mouse mesenteric resistance
arteries is due to an increase in basal NO level which is mediated via a
PPAR-γ-dependent mechanism. The arteries taken from C57 mouse were
suspended in myograph for isometric tension measurement. Incubation of
telmisartan (0.1-10 µmol/L) for 24 hours reduces 9,11-dideoxy-11α,9αepoxymethano-prostaglandin F 2α (U46619)-induced contractions in a
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concentration-dependent manner. Co-treatment of the rings with 300 nmol/L
GW9662 (a PPAR-γ antagonist) antagonized the effect of 10 µmol/L
telmisartan. The inhibitory effect of telmisartan (10 µmol/L) on contractions
was prevented by actinomycin D (10 µmol/L). Both a NO synthase inhibitor,
N G -nitro-L-arginine methyl ester, and a guanylyl cyclase inhibitor
1H [1,2,4] oxadizolo-[4,3-a]quinoxalin-1-one, abolished the telmisartan
(10 µmol/L)-induced inhibition of U46619-elicited contractions. The present
results suggest that additional endothelial NO production is probably the
mechanism that accounts for the telmisartan-induced inhibition of
vasoconstriction and the NO production is likely to be PPAR-γ-dependent.
(Supported by GRF grants and CUHK LKS Institute of Health Sciences)
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DPP4 INHIBITOR SITAGLIPTIN PROTECTS AGAINST
ENDOTHELIAL DYSFUNCTION IN SPONTANEOUSLY
HYPERTENSIVE RATS
LM Liu,1 XY Tian,1 WT Wong,1 J Liu,1 AM Xu,2 KS Lam,2 X Yao,1 Y Huang1
Institute of Vascular Medicine and School of Biomedical Sciences, The
Chinese University of Hong Kong; 2Department of Medicine, The University
of Hong Kong, Hong Kong

1

increased phosphorylation of eNOS at Ser1177 in cultured endothelial cells.
Moreover, sitagliptin and exendin-4 enhanced nitric oxide production in
primary culture of SHR aortic endothelial cells, which was blocked by
exendin 9-39. In conclusion, the novel results suggest that sitagliptin
improves endothelial function in SHR by increasing NO bioavailability,
which provides functional implications of the GLP-1 signaling pathway in
the cardiovascular system. (Supported by GRF and CUHK LKS Institute of
Health Sciences)

Sitagliptin, a highly selective DPP-4 inhibitor, acts by inhibiting the
inactivation and degradation of glucagon like peptide-1 (GLP-1) and glucosedependent insulinotropic polypeptide (GIP), is an effective anti-diabetic drug
for the treatment of type 2 diabetes. Little is known about the beneficial
effects of sitagliptin against vascular dysfunction associated with
hypertension. The present study aimed to investigate whether sitagliptin
can protect endothelial function in spontaneously hypertensive rat (SHR).
Changes in vascular tone were studied in myograph and the protein
expression was detected by Western blotting. The level of nitric oxide was
determined by confocal microscopy using DAF-FM fluorescent dye in
primary culture of SHR aortic endothelial cells. 12-hr treatment with
10 µM sitagliptin or 10 nM GLP-1 agonist exendin-4 both augmented the
acetylcholine-induced endothelium-dependent relaxations in SHR renal
arteries and these effects were abrogated by GLP-1 receptor antagonist
exendin 9-39. Three-week treatment with sitagliptin led to a significant
improvement in endothelium-dependent relaxations in SHR renal arteries.
The protective effect of sitagliptin was abolished by exendin 9-39, while
exendin 9-39 had no effect on acetylcholine-induced endothelium-dependent
relaxations in SHR and WKY renal arteries. Sitaglitapin treatment also

P6.
PHARMACOLOGICAL INHIBITION OF ADIPOCYTE-FATTY
AC I D B I N D I N G P R OT E I N ( A - FA B P ) I M P R OV E S
ENDOTHELIAL FUNCTION IN MALE APOLIPOPROTEIN
E-KNOCKOUT MICE
MYK Lee,1 PM Vanhoutte,1 AM Xu1,2
1
Department of Pharmacology and Pharmacy; 2Department of Medicine,
Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

but not that to A23187 without affecting the plasma lipid profile. In
conclusion, A-FABP was detected in male atherosclerotic-prone ApoE-/- mice
since the age of 12 weeks. Endothelial dysfunction was observed as early as
at 8 weeks of age and deteriorated until 18 weeks, as judged from the reduced
relaxations to acetylcholine, UK14304 and A23187. Endothelial dysfunction
can be alleviated by treatment with an A-FABP inhibitor, suggesting that
A-FABP may be a novel target for the treatment of endothelial dysfunction.

Adipocyte-fatty acid binding protein (A-FABP) modulates inflammatory
responses in macrophages and may play a role in formation of foam cells
and atherosclerotic plaques. A-FABP is markedly upregulated in regenerated
porcine coronary arterial endothelial cells. The project were designed to
investigate the presence (or not) of A-FABP as well as endothelial function
at early stages of atherosclerosis in the aorta of 8, 12 and 18 weeks old male
C57 apolipoprotein E-knockout (ApoE-/-) mice. The effect was determined
by treatment with a selective A-FABP inhibitor, BMS 309403, in 12-weeks
old ApoE-/- mice. A-FABP was detected by immunoflorescent staining in
the endothelium of the aorta at 12, but not 8 weeks. In myograph experiments,
the endothelium-dependent relaxations to acetylcholine and UK14304
(a selective α 2-adrenoceptor agonist) were reduced significantly in the
ApoE -/- mice at 8 and 12 weeks on, respectively, compared to those obtained
in wild type mice. Relaxations to the calcium ionophore A23187 were
diminished significantly only from 18 weeks. Treatment with the A-FABP
inhibitor significantly improved the relaxation to acetylcholine and UK14304
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INVOLVEMENT OF CFTR AND KATP CHANNEL IN
ACIDOSIS-INDUCED ATP RELEASE FROM L6 CELLS
GY Le,1 J Tu,2 HJ Ballard3
School of Biomedical Sciences, The Chinese University of Hong Kong;
2
Institute of Cardiovascular Science, Chinese Academy of Sciences, Shenzhen,
China; 3Department of Physiology & Institute of Cardiovascular Science and
Medicine, The University of Hong Kong, Hong Kong
1

Introduction: In our earlier study in dog skeletal muscle, muscle contractions
brought about an increase in interstitial adenine nucleotides and a decrease
in muscle pH. Depression of the pH of rat soleus or EDL muscle with lactic
acid infusion also stimulated ATP release, which could be inhibited by
CFTRinh172, an inhibitor of CFTR, or glibenclamide, an inhibitor of both
KATP channels and CFTR.
Objectives: In this study, we used RNA interference to selectively silence
expression of the channel proteins, in order to confirm whether both CFTR
and KATP channels are involved in pH-depression-induced ATP increase.
Methods: Specific siRNAs for CFTR and the KATP channel were transfected
into L6 cells, followed by lactic acid treatment for 3 hours. As a control,
other L6 cells were transfected with the siRNA for MAPK, a protein unrelated
to ATP release. The protein expression of MAPK, CFTR and the KATP
channel was determined by Western Blotting, and the effects of pH depression
on the accumulation of ATP and adenosine in the culture medium were
determined using HPLC.

Results: The protein expression of MAPK, CFTR and KATP channel was
decreased significantly after siRNA knock down. Lactic acid treatment
significantly increased the accumulation of ATP and adenosine in the medium
surrounding the L6 cells in non-transfected cells. Silencing of MAPK did
not affect the lactic-acid-induced ATP release, but silencing of either CFTR
or the KATP channel abolished the lactic-acid-induced increases in
extracellular ATP and adenosine.
Conclusions: Lactic-acid-induced pH depression stimulated ATP release
from L6 cells, which may involve both CFTR and the KATP channel.

P8.
PUERARIN PROTECTS AGAINST HIGH GLUCOSEI N D U C E D A P O P TO S I S B Y I N H I B I T I N G C A L PA I N
ACTIVATION IN HUVECS
XH Meng,1 MZ Zheng,2 WY Zheng,1 L Zhu,1 YL Shen,1 YY Chen1
Department of Physiology, Zhejiang University School of Medicine,
Hangzhou, 310058, China; 2Department of Pharmacology, Zhejiang Medical
College, Hangzhou, 310053, China

1

(II) abolished the inhibitive effect of puerarin on high glucose-induced
calpain and caspase-3 activation, and apoptosis.
Conclusion: The data show that puerarin protects against high glucoseinduced endothelial cells apoptosis by a mechanism involving upregulation
of HO-1 expression and inhibition of calpain activity.

Objectives: The aim of this study is to investigate whether puerarin could
protect against high glucose-induced apoptosis by suppressing calpain
activation in human umbilical vein endothelial cells (HUVECs).
Methods: HUVECs were exposed to normal glucose (5.5 mmol/L) or high
glucose (33 mmol/L) for 48 h. Then cell apoptosis and caspase-3 activity
were determined. The expression of heme oxygenase-1 (HO-1) mRNA was
evaluated by RT-PCR analysis. The activation of calpain and HO activity
were also detected.
Results: Compared with the normal glucose group, exposure of HUVECs
with high glucose for 48 h resulted in the significant increases in calpain
and caspase-3 activity, and apoptosis, which were prevented by co-incubation
with puerarin (10-6, 10-5, or 10-4 mol/L) in a concentration-dependent manner.
HO-1 mRNA expression and HO activity were decreased in HUVECs treated
with high glucose for 48 h. Compared with high glucose group, co-incubation
HUVECs with puerarin and high glucose induced the increases in HO-1
mRNA expression and HO activity. HO-1 inhibitor protoporphyrin IX zinc

57

October 2009

J HK Coll Cardiol, Vol 17

ICSM, THE THIRTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Posters:
P9.
HIGH CONCENTRATIONS OF EPIGALLOCATECHIN
GALLATE INDUCE CONTRACTIONS OF THE RAT AORTA
DUE TO PRODUCTION OF REACTIVE OXYGEN SPECIES,
ACTIVATION OF CYCLOOXYGENASE, PRODUCTION OF
PROSTANOIDS AND STIMULATION OF TP-RECEPTORS
ZM Li, MWL Koo, RYK Man, PM Vanhoutte
Department of Pharmacology & Pharmacy, The University of Hong Kong,
Hong Kong
Objective: Although regular consumption of green tea is believed to be
beneficial for the cardiovascular system, a previous study revealed that high
concentrations of the green tea catechin epigallocatechin gallate (EGCG)
causes contractions of the aorta of spontaneously hypertensive rats (SHR).
The present studies were aimed to investigate the mechanisms underlying
these EGCG-induced contractions.
Methods & Results: Isometric tension was measured in isolated aortic rings
from 36-week-old male SHR. From 10 -6 to 10 -4 M EGCG induced
concentration-dependent contractions in preparations both with and without
endothelium, which were potentiated by L-NAME (inhibitor of endothelial
NO synthase) and abolished by indomethacin (inhibitor of cyclooxygenases)
or the thromboxane-prostanoid (TP) receptors antagonist S18886. The
extracellular antioxidants SOD and catalase and the intracellular antioxidants
apocynin, DETCA and deferoxamine, but not tiron partly reduced the
response, while the combined treatment with all intracellular antioxidants
abolished the contractions. The release of prostanoids end-products
[including prostaglandin F1α, prostaglandin F2α and thromboxane B2] was
significantly increased by EGCG as measured by enzyme immunoassay kits.

The intracellular reactive oxygen species (ROS) concentration was measured
by confocal microscopy. A burst of ROS was observed upon exposure to a
10-4 M of EGCG, which was unaffected by indomethacin or S18886, but
was attenuated in the presence of antioxidants.
Discussion & Conclusions: In the rat aorta, high concentrations of EGCG
induce contractions through the production of ROS, activation of
cyclooxygenase, production of prostanoids and stimulation of TP receptors.
The production of ROS is the initial step, and can be attributed to pro-oxidant
effects of EGCG. This burst of ROS leads to the activation of cyclooxygenases
in both the endothelium and the vascular smooth muscle, followed by the
production of prostanoids. These prostanoids in turn stimulated TP receptors
and finally caused contraction.

P10.
PROTEIN TYROSINE KINASES REGULATE HUMAN
CARDIAC Kv4.3 CHANNEL
YH Zhang, CP Lau, HF Tse, GR Li
Department of Medicine, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong

Conclusion: These results demonstrate that hKv4.3 channel is regulated by
both EGFR kinase and Src-family kinases. EGFR and Src-family kinases
favor tyrosine phosphorlation of the channel, and therefore may affect the
cardiac electrophysiology.

Background. The transient outward K+ current Ito (encoded by Kv4.3) plays
an important role in the phase 1 rapid repolarization of cardiac action
potentials in the heart. Modulation of Ito by intracellular signal transduction
is not understood. The present study was designed to determine whether
hKv4.3 channel (α-subunit of human cardiac I to) is regulated by protein
tyrosine kinases (PTKs) in HEK 293 cells stably expressing human Kv4.3
gene using a whole-cell patch clamp technique.
Results. It was found that human cardiac Kv4.3 current amplitude
was remarkably inhibited by the broad-spectrum PTK inhibitor genistein
(10 µM), and the inhibition was partially antagonized by the protein tyrosine
phosphoatases (PTPs) inhibitor orthovandate (1 mM). It is interesting that
the selective EGFR (epidermal growth factor receptor) kinase inhibitor
AG556 (10 µM) reversibly reduced Kv4.3 current, and the inhibitory effect
was almost fully countered by orthovandate. In addition, the Src-family
kinase inhibitor PP2 (10 µM) also decreased hKv4.3 current and the effect
was partially antagonized by orthoavanadate. Immunoprecipitation and
Western blot analysis revealed that tyrosine phosphorylation level of hKv4.3
channel was reduced by genistein, AG556 or PP2. Their reduction of hKv4.3
channel phosphorylation level was reversed by orthovanadate.

J HK Coll Cardiol, Vol 17

October 2009

58

ICSM, THE THIRTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Posters:
P11.
LARGE-CONDUCTANCE Ca2+-ACTIVATED POTASSIUM AND
ETHER-À-GO-GO POTASSIUM CHANNELS REGULATE
PROLIFERATION OF HUMAN MESENCHYMAL STEM
CELLS
YY Zhang, HF Tse, CP Lau, GR Li
Department of Medicine, The University of Hong Kong, Hong Kong
Background: Bone marrow-derived mesenchymal stem cells (MSCs) are a
promising cell source for regenerative medicine; however, cellular
physiology is not fully understood in human MSCs. The present study was
to explore the potential role of the dominant functional ion channels, largeconductance Ca 2+ -activated potassium (BKCa) channel, ether-à-go-go
potassium (hEAG1) channel, and sodium channel, in regulating proliferation
of human MSCs using whole-cell patch clamp and cell proliferation assay
approaches.
Results: We found that the BKCa channel blocker paxilline (1 µM) almost
fully inhibited BKCa current (from 6.76±0.99 pA/pF of control, to
0.02±0.09 pA/pF at +100 mV, n=5, P<0.05) in human MSCs. The hEAG1
channel blocker astemizole (0.5 µM) significantly reduced hEAG1 current
from 4.28±1.86 pA/pF to 1.40±1.13 pA/pF at +50 mV, n=6, P<0.05). The
MTT experiment showed that paxilline at 0.3, 1.0, and 3.0 µM reduced cell
proliferation to 97.2, 84.4, and 48.7% of control, respectively, and astemizole
at 0.3, 0.5, and 1 µM decreased cell proliferation to 96.5, 80.5, and 45.8%,
respectively. However, the sodium channel blocker tetrodotoxin (1 µM, fully
blocked sodium current) had no effect on proliferation in human MSCs.

3

H-thymidine incorporation assay demonstrated that both paxilline and
astemizole reduced DNA synthesis rate in a concentration-dependent manner.
Flowcytometry analysis displayed that inhibition of BKCa channel with
1 µM paxilline or hEAG1 channel with 0.5 µM astemizole accumulated
cells at G0/G1 phase (from control 68.9% to 80.5% for paxilline; to 79.2%
for astemizole).
Conclusion: Our results demonstrate that BKCa and hEAG1 channels, but
not sodium channel, participate in the regulation of cell proliferation by
promoting G0/G1 cells into cell cycling progression.

P12.
AMELIORATION OF HYPERGLYCEMIA-INDUCED
MITOCHONDRIAL ROS GENERATION OF SINGLE
PANCREATIC ISLET β-CELLS OF OBESE/DIABETIC MICE
BY CHRONIC N-ACETYL-L-CYSTEINE
CCW Poon, 1 ALS Au, 1 TQ Zhang,1 SK Kong, 2 AHP Ho, 3 GPH Leung,4
YW Kwan1
1
School of Biomedical Sciences, Faculty of Medicine, The Chinese University
of Hong Kong; 2Department of Biochemistry, Faculty of Science, The Chinese
University of Hong Kong; 3Department of Electronic Engineering, Faculty of
Engineering, The Chinese University of Hong Kong; 4Department of
Pharmacology and Pharmacy, Faculty of Medicine, The University of Hong
Kong, Hong Kong
Background: Mitochondria are the principal source of reactive oxygen
species (ROS) in pancreatic islets β-cells and impairment of mitochondrial
functions is intrinsically related with diabetes mellitus. Hyperglycemiainduced ROS production by mitochondria is an important aspect in β-cell
glucose toxicity. However, most previous studies were performed in either
normal islets/single β-cells or insulinoma cells which were bathed in high
glucose medium which could not mimic the pathophysiological conditions.
Objectives: To compare and measure hyperglycemia-induced mitochondria
ROS generation of primary pancreatic islet β-cells of obese/diabetic (+db/
+db) and lean/control (+db/+m) mice, and the effects (acute and chronic)
of N-acetyl-L-cysteine (NAC) on ROS generation.

59

Methods: Collagenase-dissociated single pancreatic islet β-cells of C57BL/
KsJ obese/diabetic (+db/+db) mice which exhibit phenotypes of the human
T2DM were harvested, and the effects (acute, 10 min; chronic, 24 h) of
NAC (20 mM) on high glucose-induced mitochondrial ROS generation were
evaluated. Mitochondrial ROS levels were estimated by MitoTracker Red
(reduced form) (a selective fluorescence probe for mitochondrial ROS
measurement) using con-focal microscope.
Results: A trend of, but a non-significant, higher resting/basal ROS level
was observed in single pancreatic β-cells of +db/+db mice compared to
+db/+m mice. High glucose (15 mM) application gradually caused an
increase in ROS levels in single pancreatic β-cells of +db/+db mice whereas
no apparent change was observed in +db/+m mice. Chronic (24 h), but not
acute (10 min), treatments with NAC (20 mM) ameliorated high-glucose
induced ROS generation in single pancreatic β-cells of +db/+db mice.
Conclusions: Hyperglycemia elicited mitochondrial ROS generation only
in single pancreatic β-cells of +db/+db mice. Chronic NAC (a well known
anti-oxidant) pre-treatment eradicated high glucose-induced ROS generation.
Current study is underway to elucidate the underlying mechanism(s) involved
in the differential effects of high glucose on ROS generation as well as the
identification of the particular mitochondrial ROS generating system.
Acknowledgements: This project was financially supported by GRF Grant
(to YWK) (Reference number: 2410565).
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APIGENIN AMELIORATES VASORELAXATION IN
DIABETIC RATS INDUCED BY STREPTOZOTOCIN
HP Wang, JF Lu, Y Chen, LB Qian, Q Xia
Department of Physiology, Zhejiang University School of Medicine / Mailbox
17, Zijingang Campus of Zhejiang University, 388 Yuhangtang Road,
Hangzhou 310058, China
Objective: To explore the effect of apigenin on endothelium-dependent
vasorelaxation in isolated rat aortic rings from streptozotocin (STZ)-induced
diabetic rats.
Methods: Diabetes was induced in male Sprague-Dawley rats by STZ
treatment (60 mg/kg i.p.) and all rats were randomly divided into a normal
control group, an apigenin control group, a diabetic group, and diabetic
groups orally administered with a low dose (10 mg/kg/d), a medium dose
(50 mg/kg/d) or a high dose (100 mg/kg/d) of apigenin for eight weeks.
Then the thoracic aorta was rapidly dissected out and the acetylcholine
(ACh)-induced endothelium-dependent vasorelaxation and phorbol 12myristate 13-acetate (PMA)-induced constriction was measured on the organ
bath system. The levels of reactive oxygen species (ROS) and the activity of
nitric oxide synthase (NOS) were measured in aortas.
Results: The blood glucose was elevated compared to citrate treated control
rats (30.2±4.4 mM vs. 4.9±0.9 mM, P<0.01) and there was an increased
aortic generation of ROS (191.5±21.1% of control, P<0.01) and a decreased
aortic constitutive NOS activity (4.0±0.5 U/mg protein in control group vs.
0.7±0.2 U/mg protein in diabetic group, P<0.01) in diabetic rats after eight
weeks of STZ treatment. Acetylcholine (ACh)-induced relaxation was
impaired (Emax: 84.3±3.6% in control group vs. 46.4±6.0% in diabetic group,

P<0.01) whereas PMA (1 µM)-induced constriction was increased (Emax:
105.9±9.2% of KCl in control group vs. 129.3±12.2% of KCl in diabetic
group, P<0.01) in aortic rings. Treatment with apigenin dose-dependently
enhanced vasorelaxation to ACh (P<0.01), markedly decreased aortic ROS
production (P<0.01) and increased NOS activity (P<0.01) in diabetic rats.
The increase of constriction to PMA was also markedly inhibited by apigenin
in diabetic rats (P<0.05).
Conclusion: The results indicate that apigenin dose-dependently reverses
the decrease of endothelium-dependent vasorelaxation in diabetic rat aortic
rings, which may be mediated by reducing PKC activity and ROS production
induced by diabetes and maintaining the activity of constitutive NOS.
Acknowledgement: This work was funded by the grant from Zhejiang
Provincial Natural Science Foundation of China (Y206179).

P14.
C A ROT I D P L AQ U E S A N D L E F T V E N T R I C U L A R
H Y P E R T R O P H Y I N O L D E R PAT I E N T S W I T H
HYPERTENSION AND DIABETES: ASSOCIATION WITH
BLOOD PRESSURE AND GLYCEMIC CONTROL STATUS
HY Wu, Y He
Institute of Geriatric Cardiology, Chinese PLA General Hospital, 28 Fuxing
Road, Beijing 100853, China
Background and Objective: Hypertension and type 2 diabetes mellitus,
which are frequently co-exist, are leading risk factors of coronary heart
disease (CHD) and stroke. Both carotid artery plaques and left ventricular
(LV) hypertrophy are well-established predictors for the occurrence of
cardiovascular events. Our study aimed to investigate the relationship
between prevalence of carotid plaque, LV mass and the control status of
blood pressure and glycemia in older patients with hypertension and type 2
diabetes.
Methods: From March 2009 to August 2009, a total of 10,468 people aged
60 years or over participated in "Health Promotion Sojourn for Retired
Cadres", a program sponsored by the China National Committee on Aging.
Before their traveling, all participants undertook a comprehensive health
examination which, in addition to a range of procedures commonly covered
by a typical annual check-up in China (measurement of blood pressure,
height and weight, fasting lipids and glucose, complete blood cell count,
urinalysis, kidney, liver, and thyroid function testing, chest X-ray,
electrocardiography), also included ultrasonography of the carotid artery
and echocardiograph examination. For subjects with a history of diabetes,
HbA1c was also measured. Data of 678 participants (512 males and 156
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females, mean age 68.3 years) with self-reported hypertension and diabetes
but without history of CHD or stroke were analyzed. A carotid plaque was
defined as a localized protrusion of the internal part of the vessel wall into
the lumen, and LV mass was determined according to the formula introduced
by Devereux et al: 0.80x{1.04x[(septal thickness + LV internal diameter +
posterior wall thickness)3 -(LV internal diameter)3 ]}+0.6 g. Blood pressure
control status was categorized into 4 groups: ideal: ≤120mmHg, adequate:
121-140 mmHg; inadequate: 141-160 mmHg, and poor: ≥161 mmHg,
according to patient's systolic blood pressure; and glycemic control status
was categorized into 3 groups: ideal: <6.5%, adequate: 6.5%-7.5%, and poor:
>7.5%, according to the HbA1c level. Differences between groups were
tested with ANCOVA. The independent relationship between plaque and
blood pressure, HbA1c level and other risk factors was tested by logistic
regression analysis. Multiple linear regression analysis was performed to
evaluate the impact of risk factors on LV mass.
Results: Among 678 participants, 392 (57.8%) had carotid plaques.
Prevalence of carotid plaque increased with poorer hypertension control
(23.3% in the ideal group to 72.8% in the poor group, P=0.003) but not
glycemic control (P=0.14). Logistic regression showed that systolic blood
pressure but not HbA1c level was significantly associated with carotid plaque
after adjustments for age, sex, body mass index, duration of smoke, total
serum cholesterol and HDL cholesterol. The mean LV mass was 176 ± 44g.
Multiple linear regression analysis showed systolic blood pressure as the
only variable significantly associated with LV mass.
Conclusion: In older patients with hypertension and diabetes, blood pressure
control rather than glycemic control, is associated with carotid artery plaques
and LV hypertrophy.
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OXIDATIVE STRESS AND LOCAL INFLAMMATION IN RAT
ADRENAL MEDULLA IN CHRONIC HYPOXIA
Y Liu, ML Fung
Department of Physiology, The University of Hong Kong, Hong Kong
Background: Chronic hypoxia (CH) leads to cardiopulmonary changes in
subjects sojourning at high altitude, and pathophysiological changes in
patients with chronic obstructive pulmonary disease. Sympathetic activation
of the adrenal medulla plays an important role in the cardiovascular response
to hypoxia. Oxidative stress triggered by a variety of stimuli including
hypoxia can mediate cellular damages with increased productions of reactive
oxygen species and free radicals in local tissues.
Hypothesis: oxidative stress induced by CH, leads to local inflammation
and cellular injury in the rat adrenal medulla.
Methods: Normoxic (N) and CH rats were exposed to air and 10% O2 for 7
days, respectively. The adrenal medulla was harvested for the measurement
of markers for oxidative stress, malondialdhyde (MDA) and nitrotyrosine
(NTR), and for the histological analysis of macrophages infiltration and
TUNEL staining for apoptosis. Also, the expressions of NADPH oxidase
subunits p22phox and NOX-4 were examined by RT-PCR.
Results: The MDA level was significantly increased in the CH group, when
compared with the Nx control. Image analysis also showed significantly
more % adrenal medulla area with positive immunostaining of NTR than

that of the Nx group. In addition, macrophage marker ED1-immunoreactivity
was remarkable in the CH group, suggesting a local inflammation. Also,
there was an increase in apoptotic cells in the adrenal medulla of CH rats.
Moreover, the mRNA expression of p22phox was increased in the CH group,
suggesting an involvement of NADPH oxidase in the oxidative stress.
Summary: Results support our hypothesis that CH-induced oxidative stress
is involved in the local inflammation and apoptosis in the adrenal medulla.
The role of the NADPH oxidase in the CH-induced oxidative stress awaits
further investigation.

P16.
C H RO N I C I N T E R M I T T E N T H Y P OX I A I N D U C E S
OXIDATIVE STRESS AND DECREASES NO PRODUCTION
IN THE CAROTID ARTERY OF RATS
CF Lau,1 KM Ng,1 GL Tipoe,2 ML Fung1
Departments of 1Physiology and 2Anatomy, The University of Hong Kong,
Hong Kong
Obstructive sleep apnea (OSA) syndrome is a risk factor of hypertension
and stroke. Chronic intermittent hypoxia (CIH) leads to oxidative stress and
tissue injury. We examined the hypothesis that CIH-induced oxidative stress
plays a pathophysiological role in the endothelial dysfunction in rat carotid
artery. Adult Sprague-Dawley rats were exposed to IH treatment mimicking
a severe OSA condition for 14 days. The carotid arteries were harvested for
the malondialdehyde assay, PCR and Western-blotting analysis, and the
measurement of nitric oxide (NO) with electrochemistry. Levels of
malondialdehyde were significantly elevated in the hypoxic group when
compared to the normoxic control. Also, the mRNA expressions of NADPH
oxidase (gp91phox, p22phox) were markedly increased in the hypoxic group,
indicating an involvement in the CIH-induced oxidative stress. In addition,
the protein level of phosphorylated eNOS (ser1177) and the NO levels were
notably lowered in the hypoxic group. These results suggest that oxidative
stress induced by the CIH treatment deteriorates the endothelial function of
the carotid artery with decreased NO bioavailability. These data may be
clinically relevant to the increased risk for cerebrovascular disease in OSA
patients.
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RESPONSE OF TRPC3 CHANNELS TO ACUTE HYPOXIA
JH Huang,1 Q Yang,1 XQ Yao,2 GW He1
1
Department of Surgery and 2School of Biomedical Sciences, The Chinese
University of Hong Kong, Hong Kong
Background & Objectives: Transient receptor potential channels (TRPs)
have been recognized as novel players in the regulation of intracellular Ca2+
concentration ([Ca2+]i) that is essential to cell function. The TRPC3 channel
is an important family member of TRPs and sensitivity of these channels to
reactive oxygen species has been demonstrated in recent studies. However,
little has been known regarding the effect of ischemia/hypoxia on these
channels. Therefore, in this study, we investigated the response of the TRPC3
channel to acute hypoxia.
Methods: Human embryonic kidney cells (HEK293 cells) were transiently
overexpressed with TRPC3 gene and exposed to either normoxia or acute
hypoxia (10 min, PO2<10 mmHg). Patch-clamp study of ionic currents was
performed in whole-cell configuration. Protein expression was determined
by western blot.
Results: Application of 1-oleyl-2acetyl-sn-glycerol (OAG, 100 µM), the
membrane permeable DAG analogue, evoked significant cation current in
TRPC3-overexpressing HEK293 cells (3.1±0.4 vs. 1.9±0.3 pA/pF, p<0.01)
but not in wild-type cells (2.0±0.4 vs. 1.9±0.4, p>0.05). Acute exposure to
hypoxia for 10 min enhanced the increase of current induced by OAG
(5.7±0.9 vs. 3.0±0.4 pA/pF in normoxia cells, p<0.05). OAG failed to induce
current change with the presence of specific anti-TRPC3 antibody in both
normoxia (1.9±0.2 vs. 2.1±0.1 pA/pF, p>0.05) or hypoxia-exposed cells

(2.0±0.4 vs. 2.4±0.4 pA/pF, p>0.05). Protein expression of TRPC3 was not
altered by acute hypoxia.
Conclusions: Acute hypoxia enhances the electrophysiological activity of
the TRPC3 channel. This may be a mechanism involved in [Ca 2+ ] i
dysregulation under hypoxic / ischemic states.
Acknowledgments: This study was supported by Hong Kong RGC grant
(CUHK4651/07M) and CUHK direct grants 2041388 & 2041384.

P18.
NITRIC OXIDE DOES NOT AFFECT THE RELEASE OF
α
ENDOTHELIUM-DERIVED CONTRACTING FACTOR PGF2α
IN THE HAMSTER AORTA
SL Wong, CW Lau, CL Au, X Yao, Y Huang
Institute of Vascular Medicine and School of Biomedical Sciences, The Chinese
University of Hong Kong, Hong Kong
We have recently observed endothelium-dependent contractions in the
young hamster aorta treated with NG-nitro-L-arginine methyl ester (L-NAME,
100 µM), an inhibitor of nitric oxide (NO) production and identified a likely
endothelium-derived contracting factor (EDCF), prostaglandin F2α (PGF2α).
However, it remains unsolved whether the masking effect of endotheliumderived NO on endothelium-dependent contractions is due to its inhibition
to the EDCF release which is mediated by COX-2 or NO plays a dominant
role counteracting the EDCF-mediated contractions of vascular smooth
muscle cells. The present study investigates the interaction between NO
and EDCF. Aortic rings from young golden hamsters (aged ~3 months) were
suspended between two stainless steel wires in myograph for the
measurement of isometric tension. The release of PGF2α was measured by
enzyme immunoassay. Endothelium-dependent contractions were elicited
by acetylcholine (ACh) only in the presence of L-NAME. Incubation of
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 3 µM) also unmasked
ACh-induced contractions. Sodium nitroprusside (SNP, 1 µM) inhibited
endothelium-dependent contractions which were unmasked by L-NAME but

J HK Coll Cardiol, Vol 17

not by ODQ. Co-incubation of L-arginine (1 mM) with L-NAME abolished
ACh-induced endothelium-dependent contractions. PGF2α elicited greater
contractions in hamster aortas without endothelium or with endothelium
treated with L-NAME. SNP attenuated the PGF 2α-induced contractions.
ACh-stimulated release of PGF2α was similar regardless of the presence of
L-NAME and SNP. Our results indicate that the presence of NO dose not
affect the PGF 2α release, but inhibits ACh- or exogenous PGF2α-induced
contractions, it is thus likely that NO exerts a downstream effect on vascular
smooth muscle cells to inhibit endothelium-dependent contractions, instead
of a direct inhibition on the COX-2 activity and subsequent PGF2α production.
(Supported by GRF and CUHK LKS Institute of Health Sciences)
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P PA R δ AC T I VAT I O N P ROT E C T S E N D OT H E L I A L
FUNCTION IN DIABETES
XY Tian,1 WT Wong,1 NP Wang,2 AM Xu,3 ST Lee,4 Y Huang1
Institute of Vascular Medicine and School of Biomedical Sciences, The
Chinese University of Hong Kong, Hong Kong; 2Institute of Cardiovascular
Sciences, Peking University, China; 3 Department of Medicine and
Pharmacology, The University of Hong Kong; 4Department of Biochemistry,
The Chinese University of Hong Kong, Hong Kong
1

Recent evidence highlights the therapeutic potential of peroxisome
proliferator-activated receptor-δ (PPARδ) agonists to increase insulin
sensitivity in diabetes. The implication of PPARδ activation in the regulation
of cardiovascular function is unclear. The present study investigates whether
PPARδ activation can improve endothelial function under hyperglycemic
conditions and in type 2 diabetes. Vascular reactivity of mouse aortas was
studied in myograph. Protein expressions were detected by Western blotting.
R e a c t ive o x y g e n s p e c i e s ( RO S ) p r o d u c t i o n wa s m e a s u r e d b y
dihydroethidium fluorescence, and nitric oxide (NO) production was
quantified by DAF-FM dye using confocal microscopy. GW0742 and
GW501516 (1 µM, PPARδ agonists) improved endothelium-dependent
relaxations, inhibited endothelium-dependent contraction induced by
acetylcholine, and suppressed the cyclooxygenase-2 (COX-2) up-regulation
in the aortas of diabetic db/db mouse. PPARδ agonists prevented
hyperglycemia-induced impairment of endothelium-dependent relaxation
in aortas of wild type mice, but not in PPARδ-/- mice. PPARδ agonists reduced
the ROS production induced by hyperglycemia and in db/db mouse aortas.

Moreover, PPARδ activation increases eNOS phosphorylation at Ser1177 and
Akt phosphorylation at Ser473, without modulating the protein expression of
total eNOS and Akt. Importantly, PPARδ activation enhanced the NO
production in cultured endothelial cells. Taken together, the present study
provides novel evidence for the endothelial protective effects of PPARδ
activation in diabetes through triggering Akt/eNOS signaling cascade,
reducing oxidative stress, and inhibiting COX-2 upregulation. The novel
findings of the present investigation provide useful insights into new
therapeutic strategies against the development of vascular dysfunction in
diabetes.

P20.
CYCLOOXYGENASE-DERIVED PROSTANOIDS MEDIATE
ENDOTHELIAL DYSFUNCTION INDUCED BY ADVANCED
GLYCATION END PRODUCTS
Y Lu, XY Tian, WT Wong, Y Huang
Institute of Vascular Medicine, School of Biomedical Sciences, The Chinese
University of Hong Kong, Hong Kong
Diabetes increases the formation of advanced glycation end products (AGEs)
on the vascular wall and AGEs are closely linked to the development and
progression of diabetic atherosclerosis. The present study tests the hypothesis
AGEs can have a direct effect on blood vessels to reduce endotheliumdependent relaxations through an increase in the production of
cyclooxygenase (COX)-derived prostanoids. Aortas from both non-diabetic
db/m+ and diabetic db/db mice were studied. Mouse aortas were incubated
for 24 hours with AGEs and their impact on vascular reactivity was assessed
in myograph. AGEs impaired acetylcholine-induced endothelium-dependent
relaxations of non-diabetic mouse aortas without affecting sodium
nitroprusside-induced relaxations. Treatment with aminoguanidine (100 µM,
AGE inhibitors) (1) prevented AGE-induced endothelial dysfunction in nondiabetic mouse aortas; and (2) improved endothelium-dependent relaxations
in db/db mouse aortas. AGE-induced effects were abolished by indomethacin
and COX-2 inhibitor (NS398, 3 µM) but not COX-1 inhibitor (sc-560,
0.3 µM), suggesting an involvement of COX-derived prostanoids in
mediating AGEs-induced damaging effects. S18886 (100 µM, thromboxaneprostanoid receptor antagonist) also abrogated the AGE-induced attenuation
in endothelium-dependent relaxations. EIA assay further revealed that AGEs
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increased PGF 2α production in mouse aortas under the stimulation of
acetylcholine. Importantly, AL8810 (1 µM, FP receptor antagonist) could
prevent AGE-induced effects. Taken together, the present results demonstrate
that AGEs impair endothelial function possibly through an increased
production of COX-2 derived PGF 2α. The novel findings of the present
investigation may provide useful insights into new therapeutic strategies
against diabetic atherosclerosis by targeting COX-2-derived PGF2α and FP
receptor. (Supported by GRF and CUHK LKS Institute of Health Sciences)
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D I F F E R E N T I A L E F F E C T S O F D P P 4 I N H I B I TO R
SITAGLIPTIN IN MODULATING VASCULAR TONE
WS Cheang, WT Wong, B Shen, CW Lau, X Yao, Y Huang
Institute of Vascular Medicine and School of Biomedical Sciences, The Chinese
University of Hong Kong, Hong Kong

investigated. The novel results obtained from the present study may help to
define the safety profile of sitagliptin in combating against vascular
complications in diabetes. (Supported by GRF and CUHK LKS Institute of
Health Sciences)

Sitagliptin, a newly developed anti-diabetic drug, inhibits the activity of
dipeptidyl peptidase-4 (DPP-4) which improves glucose homeostasis in
diabetes. Little is known about the effects of sitagliptin in the modulation
of vascular function. The present study examined its impact on the vascular
tone in several types of blood vessels isolated from male Sprague-Dawley
rats. The artery was suspended in organ bath or in myograph for measurement
of isometric force. Sitagliptin causes concentration-dependent relaxations
in phenylephrine-contracted aortas, carotid, femoral, and renal arteries and
the presence of endothelium plays a role in aortas and femoral arteries but
not in other arteries. In contrast, sitagliptin produces a contractile effect in
coronary arteries, which can be reversed by nifedipine (voltage-sensitive
calcium channel blocker) and pinacidil (potassium channel activator).
Sitagliptin-induced contraction in coronary artery is dependent on
extracellular calcium ions, but is independent of the presence of endothelium.
The results suggest that sitagliptin may exert a direct effect on arteries,
probably by elevating intracellular free calcium concentration in rat coronary
artery smooth muscle while producing the opposite effects in smooth muscle
cells of other systemic arteries. The detailed mechanisms are being

P22.
RELATIONSHIP OF GENETIC VARIANTS IN GENE
ENCODING ADRENOMEDULLIN WITH HYPERTENSION
AND DYSGLYCAEMIA IN HONG KONG CHINESE
KL Ong,1 AWK Tso,1 RYH Leung,1 SS Cherny,2 PC Sham,2 BMY Cheung,1
KSL Lam1
1
Department of Medicine; 2Department of Psychiatry and Genome Research
Centre, The University of Hong Kong, Hong Kong

with prevalent or incident hypertension. Although dysglycaemia was not
significantly associated with any of the SNPs at baseline, the minor A allele
of the SNP rs11042725 was significantly associated with the development
of dysglycaemia during follow-up (OR=1.30, P=0.018) and dysglycaemia
at follow-up (OR=1.24, P=0.0093), after adjusting for covariates.
Conclusion: Our study provides preliminary evidence for a role of the
adrenomedullin gene in influencing blood pressure and the development of
diabetes.

Introduction: Adrenomedullin (AM) is a vasodilatory peptide that acts
directly via cAMP and indirectly via endothelial nitric oxide. It also facilitates
the differentiation of pre-adipocytes and affects lipolysis and glucose uptake.
Therefore, we investigated the association of common genetic variants in
the gene encoding adrenomedullin (ADM) with hypertension and
dysglycaemia in the Hong Kong Chinese population.
Methods: We genotyped 4 SNPs of ADM, rs3814700, rs11042725,
rs34354539 and rs4910118, in 1936 subjects from the Hong Kong
Cardiovascular Risk Factor Prevalence Study-2 (CRISPS-2), which has a
median follow-up time of 6.4 years. Dysglycaemia includes impaired fasting
glucose (≥6.1 mmol/L), impaired glucose tolerance (2h glucose ≥7.8 mmol/L)
and diabetes.
Results: The minor T allele of SNP rs4910118 was significantly associated
with lower systolic blood pressure (β=-0.057, P=0.0079) and mean arterial
pressure (β=-0.054, P=0.014) at baseline after adjusting for covariates, but
not at follow-up. However, none of the SNPs was significantly associated
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PHOSPHODIESTERASE INHIBITION AMELIORATES TP
R E C E P T O R - M E D I AT E D I M PA I R M E N T O F
VA S O R E L A X AT I O N I N D U C E D B Y C Y C L I C A M P ELEVATING DILATORS
CQ Liu,1,2,3 HL Ru,1 SL Wong,3,4 FP Leung,3,4 XY Tian,3,4 CW Lau,3 LM Lu,2
XQ Yao,3,4 ZY Chen,4,5 Y Huang,3,4
1
Department of Physiology, Hangzhou Normal University, China; 2Department
of Physiology and Pathophysiology, Fudan University Shanghai Medical
College, China; 4Institute of Vascular Medicine and 3School of Biomedical
Sciences, The Chinese University of Hong Kong, Hong Kong; 5Department
of Biochemistry, The Chinese University of Hong Kong, Hong Kong

(PDE3 inhibitor), rolipram (PDE4 inhibitor) or by Y27632 (RhoA/Rho kinase
inhibitor), but not by T0156 (PDE5 inhibitor). U46619 diminished
isoprenaline- or forskolin-stimulated rise in cyclic AMP and this effect was
inhibited by cilostazol or rolipram.
Conclusions: The present results suggest that activation of TP receptors
impairs cyclic AMP-dependent vasorelaxations partly via PDE- and RkoA/
Rho kinase-dependent mechanisms.

Objects: To examine whether stimulation of TP receptors impairs
endothelium-independent relaxations to cyclic AMP-elevating agents via
increasing the activity of phosphodiesterases (PDE).
Methods: Rat carotid arteries without endothelium were isolated and
suspended in myograph for the measurement of changes in isometric tension;
the tissue content of cyclic AMP was assayed by enzyme immunoassay kit;
and TP receptor was detected in vascular wall by immunohistochemistry.
Results: In phenylephrine-contracted rings, relaxations induced by
isoprenaline (receptor-mediated) and forskolin (receptor-independent) were
markedly reduced by the presence of U46619; the attenuated relaxations
were prevented by acute treatment with S18886, the selective TP receptor
antagonist but not by protein kinase C inhibitors. The reduced relaxations
were partially restored by IBMX (non-selective PDE inhibitor), cilostazol

P24.
RELATIONSHIP BETWEEN ABACAVIR AND RISK FACTORS
OF CARDIOVASCULAR DISEASES
RWS Li,1 YW Kwan,2 GPH Leung1
Department of Pharmacology and Pharmacy, The University of Hong Kong;
2
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong
Kong

1

The use of abacavir (a nucleoside reverse transcriptase inhibitor), in the
treatment of HIV infection, has been shown to increase the risks of stroke
and myocardial infraction.1 The underlying mechanism is hitherto unclear.
It is known that thrombosis and endothelial dysfunction are closely related
to the development of these cardiovascular disorders. Therefore, we
hypothesized that administration of abacavir may result in the damage on
endothelial functions or acceleration of thrombotic process.

Our results showed that the maximum relaxations of both basilar artery and
mesenteric artery by acetylcholine were not different between the control
group and abacavir-treated group, though the value of IC50 was larger in the
control. The data of QPCR and Western blotting showed that there were no
significant change in the mRNA and protein levels of eNOS, COX-1, COX2 and ICAM-1 in aorta after the treatment with abacavir. However, a higher
plasma level of CD40L was detected in the abacavir-treated group.
The results of this study suggested that abacavir upregulates the platelet
activity, which may increase the chance of thrombosis and result in a higher
risk of cardiovascular events.

Sprague-Dawley rats (330-350 g) were treated with abacavir (16 mg/kg/
day) for 28 days by gavage. Isometric tensions of basilar artery and
mesenteric artery were measured. Messenger RNA and proteins expressions
of factors related to endothelial function and inflammation were measured
by QPCR and Western blotting, respectively. In addition, the plasma level
of CD40L, a platelet-derived factor which is commonly used as a marker of
platelet activation, was measured by ELISA kit.
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MELAMINE AND ITS DERIVATIVE CYANURIC ACID
IMPAIR RENOVASCULAR FUNCTION AND REDUCE RENAL
BLOOD FLOW IN RATS
WT Wong,1 XY Tian,1 CW Lau,1 YX Wang,2 CM Lau,3 CS Mok,3 YL Wong,3
ZY Chen,4 Y Huang1
1
Institute of Vascular Medicine, School of Biomedical Sciences, The Chinese
University of Hong Kong; 2Department of Radiology, The Chinese University
of Hong Kong; 3Hong Kong Government Laboratory; 4Department of
Biochemistry (Science), The Chinese University of Hong Kong, Hong Kong

vehicle-treated arteries. Combined treatment of melamine and cyanuric acid
for 5 days led to a significant reduction of renal blood flow as detected by
fMRI, while melamine or cyanuric acid alone had no effect. The results
from the present study suggest that chronic exposure to high dose of
melamine can damage renovascular function, probably through increases in
cyclooxygenase-derived prostanoids which act on the TP-receptor to reduce
the EDR and cause EDC in renal arteries. The detailed mechanisms
underlying renovascular dysfunction caused by melamine and its derivative
cyanuric acid are currently under investigation. (Supported by HKSAR Food
and Health Bureau Grant)

The contamination of milk products with melamine in Mainland China
caused a widespread public health concern. The present study aims to
examine whether ingestion of melamine and cyanuric acid can impair
renovascular function and reduce renal blood flow in rats. Melamine
(60, 300 or 600 mg/kg/day) and cyanuric acid (150 mg/kg/day) were
administered to 5-week-old rats daily. Vascular function of isolated intralobal
renal arteries was assessed in myograph. Renal blood flow was examined
by functional magnetic resonance imaging (fMRI). Chronic administration
of melamine at 600 mg/kg/day to rats for 3 months significantly reduced
acetylcholine-induced endothelium-dependent relaxations (EDR) in renal
arteries without altering sodium nitroprusside-induced endotheliumindependent relaxations. Chronic exposure to melamine also augmented the
endothelium-dependent contractions (EDC) in renal arteries. Acute 30-min
incubation of thromboxane-prostanoid (TP)-receptor antagonist (S18886,
100 nM) in melamine-treated arteries rescued the impaired EDR and
abolished the augmented EDC. By contrast, S18886 did not affect EDR in

P26.
RO S D O E S N OT C O N T R I B U T E T O T H E AC U T E
DEVELOPMENT OF NITROGLYCERINE TOLERANCE IN
RAT AORTAS
JH Dong, SL Wong, XY Tian, HK Lee, WY Lee, CW Lau, X Yao, Y Huang
Institute of Vascular Medicine, School of Biomedical Sciences, Departments
of Chemistry and Pharmacy, The Chinese University of Hong Kong, Hong
Kong

activity of NAD(P)H oxidase and ROS levels in the vascular wall are being
carried out. The preliminary results indicate that ROS may not be involved
in the acute occurrence of nitroglycerine tolerance. However, it is still unclear
whether chronic treatment with antioxidants can delay the development of
nitroglycerine tolerance (supported by CUHK LKS Institute of Health
Sciences).

The development of nitrate tolerance limits the clinical efficacy of nitric
oxide (NO) donors. Several cellular mechanisms have been proposed to
explain nitrate tolerance and the increased production of ROS is one of the
possibilities. The present study examined if ROS participated in
nitroglycerine tolerance which occurs acutely in aortas isolated from male
Sprague-Dawley rats. The aortas were exposed to 30 µM nitroglycerine (with
and without pre-incubation of ROS inhibitors) for 90 min and rinsed out
four times before phenylephrine was added to cause a steady contraction.
Subsequently, nitroglycerine was added cumulatively to the bathing solution
to induce relaxations. Nitroglycerine-induced relaxations were severely
reduced after 90 min-nitroglycerine exposure. Treatment with apocynin,
tempol and tiron plus DETCA did not rescue the impaired relaxations.
Angiotensin II, H2O2 and hypoxanthine plus xanthine oxidase (which can
generate ROS as determined by electron paramagnetic resonance) did not
impair nitroglycerine-induced relaxations. The studies on changes in the
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INVOLVEMENT OF PLASMA MEMBRANE MONOAMINE
TRANSPORTER IN SEROTONIN UPTAKE IN VASCULAR
SMOOTH MUSCLE CELLS
EYW Ho,1 ASM Sit,1 RWS Li,1 YW Kwan,2 GPH Leung1
1
Department of Pharmacology and Pharmacy, The University of Hong Kong;
2
Department of Pharmacology, The Chinese University of Hong Kong, Hong
Kong
Serotonin (5HT) is a potent vasoconstrictor. It has been reported that 5HT
can be taken up by the rat aortas through the serotonin transporters (SERT).
This 5HT uptake mechanism may play a crucial role in fine-tuning the
availability of 5HT at its cognate receptors. However, many studies have
demonstrated that a significant part of 5HT uptake in blood vessels is
insensitive to the blockade by SERT inhibitor fluvoxamine, suggesting that
other transport system(s) are also involved in the 5HT uptake in blood vessels.
Plasma membrane monoamine transporter (PMAT) is a novel polyspecific
organic cation transporter that can transport organic cations such as 5HT.
PMAT is strongly expressed in kidney and brain. However, it is hitherto
unclear whether PMAT is present in blood vessels.

[3H]5HT uptake in HBVSMCs was increased with time and was saturable
with a Michaelis-menten constant of 50.36±10.2 mM. This low affinity of
5HT transport was consistent to the characteristics of PMAT. Moreover,
30% of the [3H]5HT uptake in HBMSMCs was inhibited after the PMAT
expression is silenced by siRNA. Interestingly, the result of semi-quantitative
RT-PCR showed that mRNA expression of PMAT in basilar arteries of
spontaneous hypertensive rats is higher than that of normal Wistar Kyoto
rats. Taken together, our study suggests that PMAT is present and is involved
in the 5HT uptake in the vascular smooth muscle cells. Upregulation of
PMAT may be associated with hypertension and it warrants further
investigation.

The aim of this work was to study the role of PMAT in 5HT uptake in
vascular cells. Results of RT-PCR demonstrated the presence of mRNA of
PMAT in human brain microvascular smooth muscle cells (HBMSMCs) but
not in human brain microvascular endothelial cells (HBMECs). The

P28.
ACUTE VASCULAR EFFECT OF ALDOSTERONE ON
RESISTANCE ARTERIES FROM NORMAL AND HEART
FAILURE RATS
XC Ru, J Cui, YF Li, LB Qian, Q Xia
Department of Physiology, Zhejiang University School of Medicine, 388
Yuhangtang Road, Hangzhou 310058, China
Heart failure is a complex disease which involves numerous genetic,
neuroendocrine and environmental factors. Some evidences have emerged
in resent years to support the direct role of aldosterone in heart failure,
independent of its regulation on blood volume and fluid, electrolyte
metabolism. This study was designed to investigate the effect of aldosterone
on resistance arteries from normal and heart failure rats. Acute heart failure
of rat was induced by coronary artery ligation. Five weeks after the surgery,
echocardiography showed the cardiac dysfunction. The hearts were then
excised and Masson trichrome staining of cross sections revealed a visible
myocardial infarction and fibrosis. Segments of third-order branches of the
mesenteric arteries were isolated for isometric tension recording. We found
that in normal rats, aldosterone (10-9 M - 10-7 M) caused further contraction
in mesenteric arteries precontracted by phenylephrine (PE, 10-6 mol/L), but
aldosterone did not cause vasocontraction in the arteries from heart failure
rats. In the mesenteric arteries from normal rats, pre-incubation of aldosterone
(3×10-8 M) for 10 min decreased the contractile response to low concentration
of PE (1×10-7 - 1×10-6 M), but enhanced the contractile response to high
concentration of PE (3×10 -6 - 3×10 -5 M). This effect was abolished by
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eplerenone (2×10-6 M), an inhibitor of aldosterone receptor. However, in
the arteries from heart failure rats, aldosterone (3×10 -8 M) decreased the
contraction induced by PE (1×10-7 - 3×10-5 M), which was partly blocked
by eplerenone (2×10-6 M). These results indicate that aldosterone has biphasic
effect on contractile response to PE of normal rat arteries, mediated by
aldosterone receptor. The effect of aldosterone on heart failure rat arteries is
monophasic, reducing the sensitivity to PE, which is partly mediated by
aldosterone receptor.
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ION CHANNELS AND THEIR ROLE IN CELL
PROLIFERATION OF 3T3-L1 PREADIPOCYTES
XH Zhang,1,2 MW Jin,2 GR Li1
Department of Medicine, Li Ka Shing Faculty of Medicine, The
University of Hong Kong, Hong Kong; 2Department of Pharmacology,
Tongji Medical College of Huazhong University of Science and
Technology, Wuhan, China

1

Background: Mouse 3T3-L1 peradipocytes are widely used for metabolic
study; however, cellular physiology (e.g. functional ion channel
expression) is not fully understood. The present study was to investigate
ion channel expression and functional role of them in regulating cell
proliferation using whole cell patch voltage clamp technique, RT-PCR,
Western blot, and cell proliferation assay in undifferentiated 3T3-L1
preadipocytes.
Results: We found that three types of ionic currents were present in 3T3-L1
preadipocytes, including a Ca2+-activated K+ current (IKCa) in 39% cells, an
inwardly-rectifying K+ current (IKir) in 15% cells, and a chloride current (ICl)
only in 8% cells under isotonic conditions. Interestingly, ICl was observed
in all cells with hypotonic (0.8T) insult, suggesting that it is a volumesensitive ICl (ICl.vol). IKir was inhibited by Ba2+, and IKCa was inhibited by the
intermediate conductance IKCa channel blocker clotrimazole. ICl was reduced
by the chloride channel blockers DIDS. RT-PCR revealed significant

expression of mRNAs: KCa3.1 for IKCa, Kir2.1 for IKir, and Clcn3 for ICl.vol.
Proteins of these channels were detected using Western blot analysis.
Proliferation assay demonstrated that blockade of IKCa with clotrimazole or
ICl.vol with DIDS inhibited cell proliferation in a concentration-dependent
manner. Flowcytometry analysis showed that clotrimazole (3 µM) and DIDS
(200 µM) accumulated the cells at G0/G1 phase (from control 49.91±2.8%
to 57.05±3.6% for clotrimazole, P<0.05; to 61.08±4.3% for DIDS, P<0.05).
Conclusions: These results demonstrate the first information that three types
of functional ion channel currents, including intermediate-conductance IKCa,
ICl.vol, and IKir, are heterogeneously present in 3T3-L1 preadipocytes. IKCa
and ICl.vol participate in the regulation of cell proliferation.

P30.
DISTINCT EFFECTS OF SIMVASTATIN ON CYTOSOLIC Ca2+
CHANGES AND Ca2+-SENSING RECEPTOR EXPRESSION OF
ISOLATED PANCREATIC ISLETS β CELLS OF OBESE/
DIABETIC MICE
ALS Au, 1 CCW Poon, 1 TQ Zhang, 1 SK Kong,2 AHP Ho, 3 GPH Leung,4
YW Kwan1
1
School of Biomedical Sciences, Faculty of Medicine, The Chinese University
of Hong Kong; 2Department of Biochemistry, Faculty of Science, The Chinese
University of Hong Kong; 3Department of Electronic Engineering, Faculty of
Engineering, The Chinese University of Hong Kong; 4 Department of
Pharmacology and Pharmacy, Faculty of Medicine, The University of Hong
Kong, Hong Kong
Background: Diabetics often have hyperlipidemia as a co-morbidity. In
previous clinical and animal studies, statins (HMG CoA reductase inhibitors)
provided cholesterol-independent beneficial effects in diabetic patients/
animal models. Activation of Ca2+-sensing receptor (CaR) resulted in insulin
release in human isolated pancreatic islets.
Objectives: To compare and measure the effects of simvastatin (SIM, a HMG
CoA reductase inhibitor) (10 nM, 24 h incubation) on protein expression of
CaR and ionomycin- and caffeine-elicited [Ca2+]i changes of single pancreatic
islet β-cells of obese/diabetic (+db/+db) and lean/control (+db/+m) mice.
Methods: Collagenase-dissociated single pancreatic islet β-cells of C57BL/
KsJ obese/diabetic (+db/+db) mice (which exhibit phenotypes of human
T2DM) were harvested. The protein expression of CaR was evaluated using
Western Blot. Ionomycin- and caffeine-induced [Ca 2+ ] i changes were
measured using Fluo-4 fluorescent imaging techniques. Glucose (5 and 15
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mM)-induced insulin release was measured (by ELISA).
Results: Protein expression of CaR, but not HMG CoA reductase, was
lowered in pancreatic islets of +db/+db mice (~60% of +db/+m mice)
compared to +db/+m mice, and it was partially restored by SIM. A relatively
small ionomycin (1 µM)- and caffeine (5 mM)-induced [Ca2+]i change was
observed in single pancreatic β cells of +db/+db mice compared to +db/
+m mice, and it was restored after SIM treatment. An attenuated glucose
(5 and 15 mM)-induced insulin release was consistently observed in the
pancreatic islets of +db/+db mice and the suppressed glucose (15 mM)induced insulin release in pancreatic islets of +db/+db mice was partially
restored by SIM.
Conclusions: The biochemical existence of HMG CoA reductase and CaR
in pancreatic islets of +db/+db and +db/+m mice was confirmed. The
suppressed ionomycin-induced [Ca2+]i and glucose-mediated insulin release
of pancreatic islets β-cells +db/+db mice could be restored by SIM
suggesting that SIM could be used in treating T2DM.
Acknowledgements: This project was financially supported by GRF Grant
(to YWK) (Reference number: 2410565)

October 2009

68

ICSM, THE THIRTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Posters:
P31.
MODULATORY EFFECTS OF SIMVASTATIN ON INSULIN
RELEASE OF PIG PANCREATIC ISLETS OF LANGERHANS
TQ Zhang, 1 IMF Wong, 1 ALS Au, 1 CCW Poon, 1 SK Kong, 2 AHP Ho, 3
GPH Leung, 4 CH Cho, 1 YW Kwan 1
1
School of Biomedical Sciences, Faculty of Medicine, The Chinese University
of Hong Kong; 2Department of Biochemistry, Faculty of Science, The Chinese
University of Hong Kong; 3Department of Electronic Engineering, Faculty of
Engineering, The Chinese University of Hong Kong; 4Department of
Pharmacology and Pharmacy, Faculty of Medicine, The University of Hong
Kong, Hong Kong
Background: Type 2 diabetes mellitus (T2DM) is a metabolic disease and
many T2DM patients have hyperglycemia as a result of deficiencies in insulin
secretion (β-cells dysfunction). A locus on chromosome 9 is linked to
cholesterol levels and DM, and diabetic patients with dyslipidemia are now
receiving HMG CoA reductase inhibitors (statins which are mainly for
lowering blood cholesterol). However, there is no consensus on whether
statins consumption can modulate insulin release in patients and animals
with DM.
Objectives: To evaluate the effects of simvastatin (SIM, a HMG CoA
reductase inhibitor) on insulin release of pig isolated pancreatic islets bathed
in glucose medium (5.6 and 25 mM), and the underlying cellular mechanisms
involved.
Methods: Fresh pig pancreases were collected from a local slaughterhouse.
Pancreas was finely cut into small pieces and isolated pancreatic islets were
handpicked under the dissecting microscope. The collected pancreatic islets
were cultured in RPMI solution supplemented with glucose (5.6 and

25 mM) with and without SIM (24 h incubation) before they were subjected
to different assays (Western blot, and insulin release using ELISA).
Results: The biochemical existence of HMG CoA reductase was confirmed,
and only the protein expression of p-HMG CoA reductase was elevated in
high glucose medium. Changing glucose from 5.6 to 25 mM resulted in ~5fold increase in insulin release. Under normal glucose (5.6 mM) condition,
SIM (10 µM) treatment (24 h) markedly enhanced (~ 9-fold) glucose-induced
insulin release. In contrast, SIM pre-treatment did not modify insulin release
from pancreatic islets bathed in high glucose (25 mM) medium.
Conclusions: The biochemical existence of HMG CoA reductase in pig
pancreatic islets was confirmed. The expression of the inactivated form of
HMG CoA reductase (p-HMG CoA reductase) was elevated under
hyperglycemic conditions. SIM pre-treatment only enhanced insulin release
from pancreatic islets bathed in normal but not high glucose medium
suggesting that SIM may not provide beneficial effects in patients with
T2DM.
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P32.
THE FLAVONOID KAEMPFEROL ENHANCES SODIUM
NITROPRUSSIDE-INDUCED RELAXATION IN PORCINE
CORONARY ARTERIES VIA ACTIVATION OF POTASSIUM
CHANNELS
MYT Lau, SWS Leung, RYK Man
Department of Pharmacology and Pharmacy, The University of Hong Kong,
Hong Kong
Kaempferol is a major flavonoid component of the Chinese medicine,
Carthamus tinctorius, which has been used to treat cardiovascular diseases.
Previous studies demonstrated that kaempferol potentiated sodium
nitroprusside (SNP)-induced relaxation at concentrations that did not directly
relax porcine coronary arteries. This study aimed to investigate the
mechanisms of this vascular action of kaempferol using organ bath technique.
In the presence of indomethacin, SNP-induced relaxation was significantly
enhanced by kaempferol in porcine coronary arteries with and without
endothelium. These potentiations were partially inhibited by iberiotoxin, a
big conductance calcium-activated potassium channel (BKCa) blocker, but
was not affected by TRAM-34 or UCL-1684, selective inhibitors of
intermediate and small conductance calcium-activated potassium channels
(IKca and SKca), respectively. Carbenoxolone, a gap junction inhibitor, and
KT5720, a protein kinase A inhibitor, also did not affect the potentiation by
kaempferol in arteries with or without endothelium. These findings suggest
that kaempferol activates BKCa in vascular smooth muscle to enhance SNPinduced relaxation in porcine coronary arteries, while IKca, SKca, protein
kinase A and gap junctional proteins do not play a role.
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